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PERCEIVED BARRIERS TO ROUTINE ADULT INFLUENZA AND PNEUMOCOCCAL VACCINATION IN 
THE EMERGENCY DEPARTMENT. Westin M. Amberge (Sponsored by Ian P. Schwartz) Dept of 
Emergency Medicine, Yale University School of Medicine, New Haven, CT. 
 Influenza and pneumococcal disease represent a substantial cause of morbidity and 
mortality, which is largely preventable with routine immunizations. The Emergency Department 
(ED) represents a unique avenue to reach a disproportionally high risk and under-vaccinated 
population. ED based programs for influenza and pneumococcal vaccinations are likely to be 
both feasible and cost effective, yet the administration of these vaccines in the ED is an 
uncommon practice. Little is known about the true prevalence of current ED based adult 
vaccination, as well as the attitudes of ED medical directors towards implementing these 
vaccination programs.  This study used an electronic survey to study the prevalence of routine 
adult vaccination practices occurring in the ED and the perceptions of ED directors regarding 
potential barriers preventing effective ED vaccination programs.  The survey was completed by 
104 ED directors throughout the northeastern US, at a mixture of rural, suburban, and urban 
hospitals, as well as academic and non-academic hospitals.  Of the 104 hospitals 45 (43%) and 
36 (35%) ED directors indicate their ED provides some amount of influenza and pneumococcal 
vaccinations respectively, but these estimates become 16.3% and 5.8% respectively when more 
conservative criteria are applied.  Thirty-seven ED directors (36%) indicated supporting the 
practice of providing routine adult immunizations in the ED.  The identified barriers to ED based 
vaccination programs are as follows: time pressure on nurses, patients inability to provide an 
accurate vaccination history, lack of needed resources to store vaccinations, time pressure on 
ED physicians, lack of an ED vaccination protocol, belief that vaccination is the sole job of 
primary care physicians, and the prohibitively high cost of a vaccination program.  On average, 
time pressure on nurses was identified as the most significant barrier to ED vaccination. It is 
likely that uniquely tailored community level solutions will be the most successful to solve the 
problem of under vaccination.  The role of the ED in these programs will likely be highly variable. 
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INTRODUCTION 
Influenza and pneumococcal disease carry significant morbidity and mortality 
      Influenza and pneumococcal disease remain among the top ten causes of death in 
the United States, despite the existence of effective preventative vaccinations targeting both 
types of infection. (1) Influenza is thought to be responsible for greater than 200,000 
hospitalizations per year with 20,000 to 40,000 deaths from influenza or its complications, 90% 
of which occur in the elderly. (2-7) These rates are often worse during years with particularly 
bad epidemics. (4, 7) Death from influenza is often due to a secondary bacterial infection, most 
commonly from Streptococcus pneumoniae (Pneumococcus).  Pneumococcal infection is the 
most common vaccine preventable bacterial infection, accounting for more deaths than any 
other bacterial infection. (8, 9) Per year, pneumococcal disease is responsible for over 500,000 
cases of community acquired pneumonia, 50,000 cases of bacteremia, 3,000 cases of meningitis, 
and more than 40,000 deaths annually. (10-13) The overall estimated incidence of bacteremia is 
15-30 cases per 100,000 people, which rises to 50-83 per 100,000 people for adults 65 or older.  
It is associated with a case-fatality rate of 15-20% among adults, climbing to 30-40% among the 
elderly. (13) One epidemiological study in the late 1990’s found 33% of the cases of invasive 
pneumococcal disease to occur in people over 65 years old, with 96% of the cases requiring 
hospitalization. (10) Pneumococcus is the most common cause of community acquired 
pneumonia, representing 30-50% of cases. (12) Of the cases of pneumococcal pneumonia, 10-
25% will progress to pneumococcal bacteremia, while 60-80% of cases of bacteremia are 
associated with a preceding pneumococcal pneumonia. (13) Collectively, older adults represent 
approximately 90% of deaths due to influenza and pneumonia. (4, 8)(4, 8, 12) As the number of 
older people continues to steadily rise with the aging Baby-Boomer population, it is to be 
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expected that the prevalence of cases of influenza and pneumococcal disease with significant 
morbidity and mortality will continue to rise as well. 
 
Influenza and pneumococcal vaccines are effective 
 Effective vaccines for the prevention of both influenza and pneumococcal infection 
exist, indicating a large percentage of the morbidity and mortality associated with these 
infections is likely preventable.  The efficacy of influenza vaccination has been found to be 70-
90% effective in preventing infection in healthy adults.  In the elderly (age ≥ 65), it has been 
shown to be 30-70% effective in reducing hospitalizations and 50-80% effective in preventing all 
cause mortality. (14-20) While it is known that the effectiveness of the influenza vaccine 
depends in part on the age and immunocompetence of the recipient as well as the correlation 
between the vaccine strains and those in circulation, the efficacy of the vaccine against 
laboratory confirmed influenza illness was 50-77% in studies conducted when the vaccine 
strains and circulating strains were antigenically dissimilar. (7, 21-23) The most recent of these 
studies indicated an effectiveness of 90%. (22) Additionally, an effective immune response to 
vaccination has been shown in both immunocompromised patients and pregnant women. (7) 
Subpopulation studies have shown a clear benefit in patients with chronic diseases including 
COPD and CHF. (24, 25) In patients 65 or older with CVD, influenza vaccination correlated with a 
60% reduction in death from all causes. (26) In 2006, the American Heart Association and the 
American College of Cardiology recommended influenza vaccination in adults with coronary 
vascular disease as a secondary prevention measure.  From a public health perspective, mass 
immunization against influenza has been proven to be helpful in reducing size and severity of 
new epidemics. (27) In the recent past, influenza vaccine has been recommended to be offered 
to all people over 50 years old.  One study estimated that offering influenza vaccine to patients 
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50 and older would prevent 2.64 million cases of influenza-like illness, 180,000 hospitalizations, 
40,500 deaths, and result in 275,000 quality adjusted life years (QALYs) saved. (28) 
 Similarly, pneumococcal vaccination has been shown to have an overall correlation with 
a reduced rate of death, complications, and patient length of stay. (29) A sero-prevalence study 
using the CDC’s pneumococcal surveillance system showed that an antigen-specific antibody 
response occurs in 80% of healthy adult recipients within two to three weeks after vaccination. 
(13) This study demonstrated a 57% overall protective effect against invasive infections caused 
by all included serotypes.  A similar antibody response is seen in the elderly, as well as in 
patients with alcoholic cirrhosis, COPD, diabetes mellitus, and asplenia; however, the antibody 
response in immunocompromised patients was noted to be diminished or absent in several 
studies.  Antibody levels often remain elevated for at least five years after the initial vaccination 
event. (13) The vaccine has been shown to be consistently effective in preventing bacteremia, 
while less effective in preventing other types of pneumococcal disease including pneumonia. 
(13) A meta-analysis of nine randomized clinical trials did not show a protective effect against 
non-bacteremic pneumonia in high risk groups. (30) Overall, it has been shown that systemic 
pneumococcal illness is preventable in 56-81% of cases by the use of the 23-valent 
pneumococcal vaccine.  Vaccination has also been shown to specifically be effective in 
preventing pneumococcal bacteremia in older patients. (13, 31-34) 
 
Rates of routine adult immunization are low 
 The CDC has listed immunization as one of the top ten public health achievements of 
the 20th century. (35) One of the main goals of the Healthy People 2010 initiative set forth by 
the U.S. Department of Health and Human Services is to increase the rate of adult immunization 
against influenza and pneumococcus to 90% or greater for adults over 65 and 60% or greater for 
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adults 18 to 64 with high risk conditions.  Despite these goals, the most recent available data 
from the National Health Immunization Survey (NHIS) indicates immunization rates far below 
these goals.  In 2006, the immunization rate for adults 65 or older against influenza and 
pneumococcus were 64% and 57% respectively.  For adults aged 18 to 64 with high risk 
conditions indicating the need for vaccination, these rates fall further to 28% and 18% 
respectively. (36) Prior studies and survey data from the NHIS have demonstrated subgroup 
analysis showing immunization rates among ethnic groups, especially Blacks and Hispanics are 
often significantly lower than that of Whites, likely reflecting a known difference in access to 
primary medical care between the groups. (37) An overarching national goal of reducing racial 
and ethnic health disparities, including disparities in vaccination coverage, is not being met. (36) 
 The populations to be vaccinated against influenza and pneumococcus represent those 
established by the Advisory Committee on Immunization Practices (ACIP) of the CDC as the 
highest risk of complications due to infection and those most likely to contribute to the spread 
of disease to this at risk population.  Specifically in regards to adults, the populations 
recommended for vaccination are as follows.  For influenza vaccination, it is recommended that 
all adults age 50 or older, pregnant women, persons with compromised immune responses, and 
persons with chronic medical conditions including pulmonary, cardiovascular, renal, hepatic, 
hematologic, malignant, or metabolic disease should be vaccinated.  In addition, all people in 
nursing homes or chronic care facilities, healthcare personnel, as well as any healthy household 
contact of a person at high risk.  Although 83% of the US population is included in one or more 
of these high risk categories, during the 2007 to 2008 flu season only 40% of the US population 
was vaccinated. (7) 
 ACIP recommendations for pneumococcal vaccination target those persons at highest 
risk of complication from infection.  These groups include all persons 65 years of age or older, 
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patients with chronic cardiovascular, pulmonary, renal, or hepatic disease, diabetes mellitus, 
functional asplenia, alcoholism, and persons with a compromised immune response.  
Additionally, all Native Americans and Alaskan natives, as well as patients residing in chronic 
care facilities are through to be at high risk as well.  Revaccination is often indicated after 5 
years from the initial vaccination.  Epidemiologic studies have indicated that approximately 91% 
of patients with pneumococcal bacteremia have at least one of the CDC listed risk factors 
indicating the need for vaccination. (13) 
 
The ED population has a high prevalence of unvaccinated, high risk patients 
 In 2006 there were 119.2 million ED visits nationwide to fewer than 4,500 EDs, 
averaging to 40.5 visits per 100 persons.  The number of ED visits has continued to rise, up 32% 
since 1996, yet the number of visits for emergent conditions has not changed since 1995. (38-
42) It is estimated that more than 20% of Americans visit an ED annually and some prefer to visit 
EDs over primary care. {{}}  
It is known that a large percentage of the ED patient population consists of people with 
chronic illness who are uninsured or under-insured with poor access to primary care, 
representing a patient population that is likely to be high risk and unvaccinated. (38, 43) The ED 
is often the primary site of contact with the healthcare system for the nation’s more than 45 
million and rising uninsured population. (44, 45) As expected, a study looking at the prevalence 
of basic primary care health provisions, found the ED patient population in particular need for 
primary care. (46) Furthermore, it has been shown that lower socio-demographic status (based 
on low income and education level) is associated with low vaccination rates. (47) Because the ED 
sees a disproportionate number of ill, elderly, poor, and minorities – all groups which are at high 
risk for both respiratory disease and under-immunization – it represents a unique venue to 
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reach an otherwise unreachable high risk population. (38)  The rate of African American 
utilization of the ED has increased to 75.4 visits per 100 African Americans, which is roughly 
double the rate for white Americans at 35.9 visits per 100 white Americans. (48)  Additionally, it 
has been shown that African American and Hispanic patients are significantly less likely to 
receive influenza and pneumococcal vaccinations. (49) The current situation represents a 
significant disparity in the treatment of various racial groups, which can potentially be remedied 
by increased ED vaccination efforts due to the high concentration of minorities in this 
population. 
 A number of studies have specifically looked at the prevalence of vaccination against 
influenza and pneumococcus in the ED population.  In a study conducted at a large, urban ED in 
Chicago, Slobodkin et al. found generally low rates of adult immunization.  During a 6 week 
period, out of 11,000 non-emergent patients, 40% were considered high risk by CDC guidelines, 
yet only 30% and 6% of these high risk patients were immunized against influenza and 
pneumococcus respectively. (50) In a follow-up study, 27% of patients were found to be at high 
risk, while only 28% and 3% reported influenza or pneumococcal immunization. (51) A study 
conducted by Rodriguez, et al. at the UCLA ED which specifically looked at all the patients over 
65 years old seen within a two month period, found respective vaccination rates of 37% and 
18% for influenza and pneumococcus. (52) In the most recent study, conducted at an inner city 
ED in New Mexico over a three week period, 69% of patients were at high risk for influenza, yet 
only 16% of these patients were previously vaccinated.  Additionally, 45% were high risk for 
pneumococcal disease, and only 18% of these patients had been previously vaccinated. (53) 
A study conducted by a group at Vanderbilt University found 57% and 75% of high risk patients 
were not currently up-to-date with influenza and pneumococcal vaccination respectively.  
Interestingly, although approximately half of high risk patients were not up-to-date with 
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vaccines, roughly 80% identified a PCP. (54) An ED based immunization study conducted in 
Canada, a nation with nationalized healthcare, found similar results to the previously mentioned 
American studies.  It was found that 65% and 62% of high risk patients were unvaccinated 
against influenza and pneumococcus respectfully and had no plans for future vaccination. (55) 
The net results from all studies looking at the vaccination rates of high risk adult ED patients 
indicate rates ranging from 16 to 43% and 3 to 25% for influenza and pneumococcus 
respectively, confirming the ED population contains a significant number of high risk 
unvaccinated patients. (50-54, 56, 57) 
 
Missed opportunities for vaccination frequently occur in the ED 
 Of the approximately 120,000 ED visits per year, only a small proportion, roughly 12.8%, 
are admitted. (38) Although many hospitals have adopted standing orders for influenza and/or 
pneumococcal immunization to eligible in-patients, these standing orders are usually not in 
place in the ED for non-admitted patients.  Even for admitted patients, one study demonstrated 
the opportunity to provide pneumococcal immunization to hospitalized elderly patients was 
missed in 80% of admissions. (58) A similar study demonstrated 36-70% of patients hospitalized 
for pneumococcal bacteremia had been inpatients at the same hospital during the previous five 
years. (59, 60) Similarly, opportunities for influenza vaccination are often missed. In a study of 
hospitalized Medicare patients, only 32% were vaccinated prior to admission, 2% during 
admission, and 10% after admission. (61) High risk patients are often seen in the ED prior to 
admission for influenza or pneumococcal disease.  In one retrospective study by Stack et al, it 
was shown that 55% of 188 patients admitted for pneumococcal bacteremia had been seen in 
that hospital’s ED within the previous six years, during which 88% had indications for 
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pneumococcal vaccination.  Furthermore, patients often had multiple missed ED vaccination 
opportunities during this timeframe, averaging 3.2 ED visits per admitted patient. (62)  
ED based vaccination programs have shown the potential to reach more high risk 
unvaccinated patients than either inpatient or general medical clinic settings.  A retrospective 
chart review for all patients with pneumococcal bacteremia admitted in a four year period 
found that 70% had risk factors indicating the need for vaccination, and that 95% of these high 
risk patients had a missed opportunity for vaccination in the five years prior to admission.  If all 
of these high risk patients had been immunized at a prior contact, 87% would have been 
immunized in the ED, compared to 50% as admitted patients and 31% at a general medical 
clinic.  This study indicated that, depending on the efficacy of the pneumococcal vaccine, 15-28 
bacteremic episodes admitted to this hospital might have been prevented with an ED 
vaccination program, as compared to 9-17 as admitted patients, and 5-10 at a general medical 
clinic. (63) 
 
ED based vaccination programs are feasible 
 Many of the previously mentioned studies looking at ED population vaccination rates 
also examined ED based interventions to provide influenza and pneumococcal vaccination to 
identified high risk and unvaccinated patients.  These studies have demonstrated that ED based 
programs are both feasible and effective at increasing immunization rates.  The first reported 
analysis of ED based adult vaccination occurred over 20 years ago by Polis et al, who was the 
first to report low vaccination rates among ED patients, and found that 60% of unvaccinated 
high risk patients would accept immunization in the ED.  He also demonstrated the potential of 
missed opportunities for vaccination, as 80% of patients not seen by a primary care provider 
(PCP) within the past three years had been hospitalized or seen in the ED during that time. (64) 
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In 1988, Polis et al. implemented a trial ED vaccination program that vaccinated 37% of high risk 
unvaccinated patients presenting to the ED.  However, this study was limited as it required PCP 
approval for vaccination, and while two groups of PCPs made blanket requests that their 
patients not be immunized in the ED, only 61% of their patients had previously been vaccinated. 
(57) 
 In the initial ED based vaccination interventions conducted by Slobodkin et al, standing 
orders were used for screening and immunization to be completed by the nursing team at 
triage.  Normal staffing levels were compared with using an additional nurse assigned to the 
triage team whose sole responsibility was screening for and providing immunizations.  This trial 
was compared to a second intervention where immunization duties were given to nurses caring 
for patients in the treatment area.   Overall, immunization in the ED was accepted by 70% and 
61% of high risk patients offered influenza and pneumococcal vaccination respectively.  Their 
analysis estimated that generalized ED based influenza vaccination could immunize 2.8 million 
high risk patients each influenza season.  Furthermore, ED based pneumococcal vaccination 
would reach 7 million patients during the first year, and 24 million over five years, beyond which 
they estimated 500,000 pneumococcal immunizations per year based on the rate of population 
growth.  In comparing the various interventions, no difference was seen in assigning vaccination 
duties to nurses at triage or in the patient care area; additionally, no difference was seen by 
adding a dedicated immunization nurse beyond normal staffing levels.  Finally, a time motion 
study of nursing activities showed the median time for all immunization activities was four 
minutes, and was not associated with noticeable delays in patient care. (50, 51) 
 A follow up study looking specifically at pneumococcal vaccination in the ED, over a 2 
month period, found that 82% of screened patients met high risk criteria for vaccination.  Of 
these patients, 84% accepted pneumococcal immunization in the ED.   This study also used 
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nursing standing orders for screening and vaccination.  The high prevalence of high risk patients 
in the study was thought to be influenced by preferential screening and documentation by the 
nursing staff, with the actual estimated high risk patient prevalence being around 44% of ED 
patients. (56) 
At UCLA, an ED immunization study by Rodriguez et al. screened only for all patients 
over 65 years old (not using all of the CDC’s high risk criteria), resulting in immunization of 50% 
and 58% of unvaccinated high risk patients against influenza and pneumococcus respectively. 
(52) Simplified screening interventions such as this potentially represent potential modification 
to vaccination criteria that can be used in EDs to vaccinate a large population while dedicating 
little additional time to the screening process. Rimple et al. at the University of New Mexico 
conducted a three week intervention in which vaccination against influenza was provided to 
67% of the high risk patients and pneumococcal vaccine to 66% of the high risk patients.  This 
intervention increased the vaccination rate of ED patients from 16% to 83% in the case of 
influenza, and 18% to 84% in the case of pneumococcus. (53) The Vanderbilt based study 
provided influenza and pneumococcal vaccine to 46% and 53% of high risk patients respectfully. 
(54) The previously mentioned Canadian study had rates of ED based immunization for influenza 
and pneumococcus of 65% and 60% of high risk patients vaccinated in the ED respectfully. (55) 
The net results of all ED based immunization interventions provided collective rates of 
vaccination of high risk unvaccinated patients ranging from 46-70% for influenza and 53-84% for 
pneumococcus. (50-54, 56, 57) 
 A corollary demonstration of the feasibility of ED based immunization is seen with the 
common ED practice of providing tetanus vaccination for patients with penetrating injuries.  A 
study analyzing vaccination practices from 1992 to 2000 estimated that 27.7 million vaccines 
were given in EDs nationwide during this period.  Of the administered vaccinations, 93% were 
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for tetanus prophylaxis.  The majority of the other 7% predominantly consisted of hepatitis and 
rabies vaccines.  Approximately 250,000 of vaccinations were for influenza and pneumococcus.  
After excluding an outlier hospital where the majority of these vaccines were administered, they 
were administered too infrequently to provide a statistically significant estimate of the national 
rate of their usage in EDs. (65) Since tetanus immunization began in EDs in the 1970s, it has 
become a common and widespread practice.  Previous literature has indicated an annual 
incidence of tetanus as 0.16 cases per million people, equating to roughly 50 cases per year. (66) 
While the low incidence of tetanus is largely attributable to effective immunization practices, it 
can be seen that the number of ED patients immunized against tetanus is clearly high, yet the 
number of patients that contract tetanus is extremely low.  Conversely, the number of ED 
patients who are vaccinated against influenza and pneumococcus is extremely low, while the 
number of ED patients presenting with these infections is clearly high.   
  
Influenza and pneumococcal vaccination is cost-effective 
 Healthcare interventions do not need to be cost saving to warrant adoption, rather they 
have to be cost effective to prove the investment in the intervention is worth the health 
benefits to be gained.  Historically, policymakers have generally considered costs up to 50,000 to 
100,000 dollars per QALY saved as acceptable costs. (67, 68)  Virtually all estimates of the cost of 
influenza and pneumococcal vaccination programs have proven to be cost effective if not cost 
saving. (14, 18, 69-71) 
 Based on 2003 population statistics and dollars, the direct medical costs of influenza 
have been estimated as 10.4 billion dollars annually, while the estimated lost earnings due to 
illness and loss of life add an additional economic cost of 16.3 billion. (72) Through the use of 
projected statistical values, the total economic burden of influenza epidemics has been 
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estimated to be an average of 87.1 billion dollars. Influenza vaccination can reduce both the 
medical costs and the indirect costs from decreased work productivity and absenteeism. (73, 74) 
The annual net cost of influenza vaccination programs is 1.5 billion dollars, resulting in a cost of 
4,600 dollars per QALY saved, which falls within reasonable cost-effective intervals.  Further 
analysis shows that the cost per QALY for immunizing patients 50-64 is 28,000 dollars per QALY.  
The cost further decreases to 980 dollars per QALY for people 65 and older when accounting for 
costs of time and travel to get the vaccination; however, the cost drops to a net cost savings of 
17 dollars per year when these costs are not accounted for as would be the case with an ED 
based immunization program. (28) Multiple studies have demonstrated substantial economic 
benefit for influenza vaccination of high risk patients, with virtually all showing cost 
effectiveness and many demonstrating cost savings. (14, 25, 70, 71, 75) A study conducted by 
the CDC or Medicare beneficiaries demonstrated costs ranging from cost saving to a cost of 145 
dollars per year of life gained. (76) 
 Additionally, pneumococcal vaccination has also consistently been shown to be either 
cost-effective or cost saving. (69, 77) In a 1997 study, pneumococcal vaccination was shown to 
be cost saving for people over 65 years of age, saving approximately 8 dollars in net medical 
costs and gaining 1.21 days of healthy life per person vaccinated.  These data suggest that 
pneumococcal vaccination is one of few interventions that both improves health and saves 
costs.  It was estimated that vaccination of 23 million unvaccinated elderly would gain 78,000 
years of healthy life and save 194 million just based on reductions in the incidence of 
pneumococcal bacteremia. (69) Pneumococcal vaccination may be even more cost effective for 
African Americans, a group overrepresented in the ED patient population, as the rates of 
pneumococcal bacteremia are more than two times the rate for Caucasians. 
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ED based vaccination programs are equally cost-effective and may have further cost-
savings beyond that of the direct medical effects of vaccination.  A number of ED vaccination 
feasibility studies have suggested that vaccination is an effective way to decrease the number of 
patients admitted to the same hospital for vaccine-preventable diseases. (50, 51, 54, 62) As the 
uninsured are over-represented in the ED population, ED based immunization programs could 
help reduce the hospitalization of uninsured patients, which would likely result in additional cost 
savings.  Slobodkin et al. estimated that ED based influenza immunization at a cost of 10 dollars 
per immunization would cost 25 million dollars per year, reduce hospitalizations by 1,000 
patients, prevent 300 premature deaths, and save 225 million dollars of treatment costs per 
year.  This study also estimated that ED based pneumococcal immunization at a cost of 15 
dollars per immunization would cost 400 million in the first 5 years and then 27 million yearly 
thereafter, would prevent 4,000 premature deaths and save two billion dollars in treatment 
costs per year. (50) As previously noted, one study of patients with pneumococcal bacteremia 
noted that 88% had been seen in the ED during the previous five years, from which it was 
estimated that an ED based vaccination program would save 400,000 dollars per year, or 
160,000 dollars per year with the most conservative estimates. (62) Influenza outbreaks are 
associated with a significant increase in the elderly use of the ED for influenza related infections, 
resulting in increased resource use, admission rates, ED length of stay, ED saturation time, 
ambulance diversion, and the number of patients leaving the ED prior to being seen.  These data 
implicate influenza outbreaks as contributing to ED overcrowding. (78-80) 
 Medicare has been paying for pneumococcal and influenza vaccination since 1981 and 
1993 respectively. (58) Furthermore, Medicare Part B reimburses for administering these 
vaccines at a rate above the inpatient diagnosis-related group payment for hospitalized patients 
providing further financial incentive for ED based immunization as opposed to inpatient based 
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programs. (81) Reimbursement is also made easier by roster billing in which hospitals need only 
submit names at Medicare numbers. (82)  Many large insurance companies and employer 
sponsored insurance plans are currently covering annual influenza vaccines, and often cover or 
offer pneumococcal vaccinations at reduced costs.  However, there are still many private 
insurance plans that require covered individuals to purchase vaccinations separately or pay 
significant co-pay.  In these instances and when vaccines are provided to the uninsured, the 
costs for the vaccine and its administration may not be reimbursed. 
 
Potential barriers to ED based immunization 
 Immunization has long been perceived as the responsibility of the primary care 
physician.  When immunization is addressed in the ED, often the main intervention consists of 
referral to primary care for immunization; however, it has been demonstrated that referring 
patients outside of the ED for immunization is ineffective at increasing vaccination rates. (83) 
Concern in regards to re-vaccination may limit an emergency physician’s (EP’s) willingness to 
administer a vaccine.  One study addressing this concern, found that self-reporting of 
vaccination status has sensitivity in the high 90’s and specificity in the 70’s.  It was determined 
that a patient’s self-reported vaccination status has a 70% positive predictive value, as validated 
against medical record documentation. (84, 85) Furthermore, the Advisory Committee on 
Immunization Practices (ACIP) of the CDC recommends that patient self-report of Influenza 
vaccination should be accepted in clinical practice as proof of vaccination status. (7)  
Experience with utilizing standing orders for the administration of routine 
immunizations indicates that ED based immunization will unlikely be limited secondary to EP 
time constraints or difficult in remembering to offer indicated immunizations.  Immunization 
programs that have relied on nurse standing orders achieved better rates of vaccination than 
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programs relying on physicians to issue patient specific orders. (86, 87) As previously indicated 
in a study by Slobodkin et al, the addition of a dedicated immunization nurse did not increase ED 
based immunization coverage above rates achieved with normal staffing levels, with a time-
motion study indicating all nursing immunization activities taking an average of 4 minutes with 
no appreciable delays in patient care. (51) 
 
Little is known about ED Directors’ perceptions of ED based immunization 
 The number of studies examining EP’s perceptions of ED based vaccination programs is 
small. A survey returned by 38 EPs in Winnipeg, found that 46% rarely and 16% never screened 
for influenza vaccination, and 57% never offered it. (88) Only three EPs (8%) reported often 
screening for and administering influenza vaccines, while 76.3% indicated willingness to offer 
routine influenza immunization.  Nine of the surveyed EPs (23.7%) were unwilling to offer 
vaccination, with eight of nine indicating immunization as the role of primary care.  A study 
based in one Tennessee ED found that physicians in this ED were generally willing to order 
vaccinations, but felt they were either too busy or would not remember to offer vaccination.  
Consensus between EPs’ and nurses’ preferences indicated that a nurse standing order 
combined with physician notification prior to administration was the most preferred approach. 
(89) A larger study by this research group surveyed the Tennessee members of the American 
College of Emergency Physicians (ACEP) using a standard mail-in survey, receiving a 50% 
response rate representing 128 EPs. (54) Eighty percent of responding EPs indicated they never 
provided influenza vaccination, followed by 9% providing it rarely (less than once per year).  
Seventy-one percent indicated never providing pneumococcal immunization, followed by 23% 
providing it rarely, with the most frequent indication being emergency splenectomy.  However, 
52% of EPs indicated they were willing to administer vaccines, indicating a significant portion of 
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EPs that are willing to provide vaccinations that are not currently providing them.  The main 
reasons cited for unwillingness to administer vaccines were a belief that vaccination is the role 
of primary care (65%), inadequate time or personnel (51%), adverse reactions (29%), and cost of 
vaccines (17%).  While this study is the largest to date, its limited by its geographic isolation to 
Tennessee EPs, which may not adequately represent the national perceptions of ED based 
vaccination.  As ED based vaccination is an emerging concept, the results of this analysis 
obtained in 1994 may have significantly shifted during the past 15 years.  Furthermore, utilizing 
standard mail as a survey method as opposed to an e-mail based survey increases the likelihood 
that practitioners with strong opinions are more likely to respond, resulting in a greater 
potential for response bias.  While the perceptions of EPs are important in the willingness to 
accept and carryout ED based vaccination programs, the impetus to begin such a program would 
likely need to arise from the EDD specifically making the opinions of these practitioners valuable 
in examining the roadblocks to ED based adult immunization programs. 
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PURPOSE, HYPOTHESIS, AIMS 
Purpose 
The academic literature is robust with studies showing the feasibility and effectiveness of ED 
based adult vaccination against pneumococcus and influenza, yet the practice of providing 
routine vaccinations in the ED has not been widely adopted.  The purpose of this project is to 
provide an estimation of the current prevalence of ED based routine adult immunization against 
pneumococcus and influenza, as well as to examine the reasons ED directors (EDD) cite as 
barriers to the provision of routine vaccinations in the ED.   
The Specific Aims of the proposed project are: 
1. To estimate the current prevalence of ED based efforts for screening for immunization 
status, immunization provision, and referral to primary care for routine adult influenza 
and pneumococcus immunization. 
2. To determine the perceived road blocks to ED based adult immunization programs for 
influenza and pneumococcus from the perspective of the EDD. 
3. To determine if certain perceived road blocks to ED based immunization programs 
correlate with hospital setting or annual ED census via subgroup analysis. 
  
The associated hypotheses are: 
1. The prevalence of EDs that routinely administer adult immunizations against influenza 
and pneumococcus will be less than 5% of the survey population. 
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2. The most commonly cited road blocks to ED based immunization programs will include 
belief that immunization is a responsibility of primary care physicians and that a lack of 
time prevents immunization screening and administration. 
3. EDDs at hospitals located in urban settings with a high annual ED census will be more 
likely to perceive time constraints placed on the staff as a road block to ED 
immunization, while the prevalence of the belief that immunization is a responsibility of 
primary care physicians will be unaffected by hospital setting or ED annual census. 
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METHODS 
Overview 
An electronic survey was designed to be sent to EDDs throughout the Northeast.  The 
survey included questions to collect information about the size and setting of the hospital, the 
current practices regarding screening for and provision of routine adult vaccinations against 
pneumococcus and influenza in the ED, and the perception of the EDD being surveyed regarding 
what he or she perceived the barriers to the use of ED based routine vaccination in his or her 
ED.  EDD contact information was collected via the internet and phone calls placed to individual 
hospital emergency departments.  The survey results were tabulated and analyzed using SPSS to 
conduct various Chi-squared tests of independence.  All aspects of the methods described below 
were completed by the primary researcher (Westin Amberge), with guidance from faculty 
advisors. 
 
Survey Creation 
The electronic survey was created and administered via the survey hosting website 
SurveyMonkey (www.surveymonkey.com). In its final version, the survey contained five 
sections: informed consent, basic hospital information, current vaccination practices, EDD 
perceptions of ED based vaccination, and an open section for comments.  See Appendix Figure 1 
for a full copy of the administered survey. 
The survey began with the informed consent of the participant in which he or she was 
informed of the purpose of the study and information regarding the privacy protection of all 
collected information.  The respondent was e-mailed a unique four digit code with the initial 
request for participation in the study.  The code was used to track responses in order to 
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segregate individuals who completed the survey and did not require follow-up and those who 
had been contacted but had not yet completed the survey. 
The first section of the survey pertained to the collection of information about the 
hospital setting in which the respondent worked.  Information regarding the location, hospital 
type, and academic affiliation were collected, along with the approximate annual number of 
adult ED visits and in-patient beds.  The second section of the survey was directed at collecting 
information about current practices regarding routine adult vaccinations in the ED.  ED directors 
were asked to estimate the frequency in which patients were screened for vaccination status 
against influenza and pneumococcus, were provided vaccinations against influenza and 
pneumococcus, and were educated and referred to primary care for vaccination.  Additionally, 
the frequency of use of standing orders for the provision of vaccinations was estimated.   These 
frequencies were estimated with the following qualitative terms: never, rarely, sometimes, 
usually, and always.  The next section of the survey used a five-point Likert scale (strongly 
disagree, disagree, neutral, agree, strongly agree) to assess the level of agreement ED directors 
had to various statements indicating potential barriers to ED based vaccination.  The potential 
barriers indicted in the survey were as follows: 
• Belief that routine immunization is the sole responsibility of primary care physicians 
• Concern over time constraints on physicians 
• Concern over time constraints on nurses 
• Need for additional resources to store and administer immunizations 
• Concern that patients are unable to provide an accurate immunization history 
• Concern over adverse effects of immunizations 
• Concern regarding medicolegal liability 
• Concern over cost of providing routine immunizations 
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• Concern that patients do not want routine immunizations to be administered in the ED 
• Concern that patients do not understand the need for routine immunizations 
• Concern that influenza and pneumococcal vaccinations are ineffective 
• Lack of structured immunization screening and administration protocol 
• Belief that the patient population at your ED is mostly up-to-date on immunizations 
The last section of the survey was an optional open comments section that allowed respondents 
to provide any additional comments they had regarding routine adult vaccination against 
influenza and pneumococcus in the ED. 
 The survey was validated for clarity and readability by four independent ED physicians 
prior to finalization and distribution. 
 
HIC Approval 
The proposed study was submitted to the Human Investigation Committee IRB of the 
Yale University School of Medicine, and approved on August 19th, 2009.  HIC # 09070054971243 
 
Study Population & Survey Administration 
 The study population enrolled in the study was defined as ED directors of acute care 
adult emergency departments located in the northeastern United States.  For the purpose of 
this study the northeastern United States was defined as including the following states: 
Connecticut, Maine, Massachusetts, New Hampshire, New York, Rhode Island, and Vermont.  
Because the total population of ED directors is relatively small, the study population was limited 
to this specific geographic region in order to obtain results that were closer to a census of a 
more limited population than a strategic sampling across the United States would allow.  
Additionally, it was thought that leveraging local relationships would allow for a higher response 
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rate to be obtained.  Comprehensive lists of hospitals in each of the included states were 
obtained from the respective state hospital associations.  Hospitals that were excluded included 
any hospital without a dedicated adult emergency department.  Such hospitals included 
dedicated pediatric hospitals, psychiatric hospitals, rehabilitation facilities, and niche specialty 
hospitals such as oncology, cardiology, or orthopedics hospitals without an associated general 
acute care ED.  Yale New Haven Hospital in New Haven, CT was excluded from the study do to its 
direct affiliation with the research project.  Additionally, hospitals where the ED director was not 
a medical doctor, hospitals with a vacancy in the position of ED director, and any other hospital 
without an identifiable ED director were excluded from the study.  Finally, for hospital groups in 
which the ED director oversaw multiple hospitals, the ED director was instructed to respond in 
regards to the primary hospital in which he or she worked.   
 For included hospitals, an extensive internet search was conducted to identify the 
emergency department director and obtain his or her e-mail address for survey administration.  
For hospitals where identification of the appropriate person was not possible via the internet, 
direct phone calls were placed in an effort to obtain the needed information.  The survey was 
directly e-mailed to ED directors along with a unique four digit identifier code used to track 
survey responses.  The e-mail contained an overview of the study and its purpose, as well as 
instructions to complete the survey and a direct hyperlink to the online survey.  As surveys were 
completed, the unique four digit code was used to check off the associated hospital and ED 
director from the list of potential respondents.  If no response was received after two weeks 
since the original e-mail was sent, a follow-up reminder was sent.  After the respondent was 
checked off as having completed the survey, the survey responses were dissociated from the 
four digit code linking the survey response to a particular ED director.  When the obtained e-
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mail address for the ED director of a particular hospital was not functional or incorrect the 
respondent was removed from the sample. 
 
 
Analysis of Results 
As surveys were completed, data were extracted from each completed survey and 
tabulated in a password secured Microsoft Excel spreadsheet on a password protected laptop in 
sole position of the primary investigator.  Data were dissociated from all identifying information 
including the unique four digit code used to track responses. 
 The aggregated data for each specific question were examined for mean and standard 
deviation.  These data were used to determine the frequencies of employment of current 
immunization related practices in the ED, the percentage of ED directors who support ED based 
routine adult immunization, as well as a relative ranking of perceived importance of the 
potential barriers to ED based vaccination programs.    
The data were transformed into binomial categorical data for analysis using the Chi-
square test of independence.  The following transformations were made to assist in analysis.  
The collected data reporting the hospital setting were simplified into hospitals in “densely 
populated areas” (by grouping “urban” and “suburban”) and hospitals in “sparsely populated 
areas” (by grouping “rural” and “small municipality”).  The data reporting hospital funding were 
consolidated into “private” and “public”, which was expanded to incorporate any responses 
from VA hospitals.    The reported results for annual ED patient census were grouped into two 
categories comprised of hospitals with less than or equal to 40,000 patients and greater than 
40,000 patients per year.  The vaccination related practices data, aimed at determining the 
frequency of screening, immunization, and other practices, were reported in the form of “never, 
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rarely, sometimes, usually, or always”.   These data were simplified into the categories “no” 
(combining “never” and “rarely”) and “yes” (combining “sometimes”, “usually” and “always”).  
The data from the responses assessing ED director agreement with the various potential barriers 
to ED based vaccination were originally reported as a five-point Likert scale (strongly disagree, 
disagree, neutral, agree, and strongly agree).  These data were simplified into three categories: 
“agree” (combining “strongly agree” and “agree”), “neutral”, and “disagree” (combining 
“strongly disagree” and “disagree”). 
 The transformed data were analyzed using multiple Chi-squared tests of independence 
on various combinations of data.  Because the Chi-squared test of independence assumes 
counts to be greater than or equal to five as it is based on the compilation of normal 
approximations, when this assumption was not met Fisher’s Exact Test was used.  See appendix 
figure 2 for a chart showing all the specific associations that were tested.  
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RESULTS 
Survey Dissemination & Response Rates 
 Overall, 399 distinct hospitals with adult acute care emergency departments were 
identified in the northeastern United States as meeting the hospital level inclusion criteria.  Of 
these 399 hospitals, ED directors and their e-mail contact information were successfully located 
for 218 hospitals.  These 218 ED directors were e-mailed a request to complete the study 
survey, of which 104 responded either with the initial request or a follow-up e-mail.  See 
appendix figure 3.  Of the 114 ED directors labeled as not responding, five began to complete 
the survey but did not finish.  The data from these five partially completed surveys were 
excluded from data analysis. The overall response rate for contacted ED directors was 47.7%, 
and surveys were completed by ED directors representing 26.1% of all hospitals with adult 
emergency departments identified in the Northeast.  The state by state response rates ranged 
from 66.7% for the state of Rhode Island to 38.4% for the state of New York.  Due to the large 
population of hospitals meeting inclusion criteria, the states of New York and Massachusetts 
represent 32% and 28% of the collected survey data respectively.  See appendix figures 4 and 5 
for state by state survey collection data. 
 
Respondent Hospital Characteristics 
 Of the hospitals represented by the 104 ED director respondents, the frequency of 
hospitals described as urban, suburban, small municipality, and rural was 44, 25, 16, and 19 
hospitals respectively.  The percentage of the results by hospital type was similarly 42%, 24%, 
16%, and 18% for urban, suburban, small municipality, and rural hospitals respectively.  See 
appendix figures 6 and 7 for graphical representations.  Seventy-one hospitals were identified by 
the ED director respondents as being majority privately funded, while 31 were identified as 
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majority public funded.  Additionally, two respondents represented the emergency departments 
of a VA hospital.  The respective percentages of the total collected results represented by each 
of these categories were 68% for private funding, 30% for public funding, and 2% for VA 
hospitals.  See appendix figures 8 and 9 for graphical representations. 
 The survey also ascertained whether the respondent hospital was academically affiliated 
(i.e. a teaching hospital) or not.  Of the 104 responses, 50 hospitals (48%) were identified as 
teaching hospitals, while the remaining 54 hospitals (52%) had no academic affiliation.  See 
appendix figure 10 for graphical representation. 
 Information regarding the number of in-patient hospital beds and the annual ED census 
was also collected.  The mean number of in-patient hospital beds was 250 beds, with a standard 
deviation of 207 beds.  For hospitals self identified as rural, small-municipality, suburban, and 
urban, the mean number of in-patient beds were 89 (σ = 75), 100 (σ = 112), 184 (σ = 102), and 
400 (σ = 218) beds, respectively.  The mean number of in-patient beds for teaching and non-
teaching hospitals were 371 (σ = 228) and 135 (σ = 93) respectively.  The mean annual ED census 
for respondent hospitals was 48,985 patients, with a standard deviation of 31,198 patients.  For 
hospitals self identified as rural, small-municipality, suburban, and urban, the mean annual ED 
census was 21,897 (σ = 12,663), 31,000 (σ = 12,175), 44,384 (σ = 19,382), and 69,989 (σ = 
33,000) patients, respectively.  The mean annual ED census for teaching and non-teaching 
hospitals was 67,050 (σ = 33,721) and 32,258 (σ = 15,727) respectively.  See appendix figures 11 
and 12 for graphical representation of the relationship between self-described setting and the 
number of in-patient beds and annual ED census.  See appendix figure 13 for a side by side 
comparison of the number of in-patient beds and annual ED census in teaching and non-
teaching hospitals. 
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Immunization Related Practices 
 ED directors were asked to indicate the frequency of which specific vaccination practices 
occurred in their respective emergency departments.  The practices included screening for 
influenza and pneumococcal immunization statuses, administration of the influenza and 
pneumococcal vaccines, the use of standing orders to administer vaccines, and education and 
referral to primary care for vaccination.  Of the 104 responses, screening for influenza 
vaccination status was reported as “never” in 24 responses, “rarely” in 24 responses, 
“sometimes” in 26 responses, “usually” in 23 responses, and “always” in 7 responses.  The 
frequencies for screening for pneumococcal vaccination status were 32, 30, 20, 15, and 7 
responses for the never, rarely, sometimes, usually, and always categories respectively.   
Fifty-nine ED directors indicated their ED never provides influenza vaccinations, leaving 
45 respondents reporting some influenza vaccination activity in their ED.  Thus, approximately 
43% of respondents indicate some amount of influenza vaccines being administered in their ED.  
Of these 45 responses, 28 indicated vaccines were provided “rarely”, 11 indicated “sometimes”, 
5 reported “usually”, and 1 respondent indicated “always” providing influenza vaccines.  
Grouping the respondents that chose “never” and “rarely” as similarly not providing 
vaccinations, then 17 of 104 respondents (16%) provide some level of influenza vaccination.  Of 
the 104 respondents, 68 indicated their EDs “never” provided pneumococcal vaccination, 
leaving 36 providing some level of vaccination, which correlates to roughly 35% of respondents.  
Of the ED directors indicating some level of pneumococcal vaccination in their respective EDs, 
30 indicated “rarely”, 3 indicated “sometimes”, 3 indicated “usually”, and zero chose “always”.  
If the respondents who chose “never” and “rarely” are once again grouped, then 6 of 104 
respondents (6%) provide some level of pneumococcus vaccination. 
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Eighty-one respondents indicated “never” using standing orders, while 6 chose 
“always”.  In regards to education and referral, the respondents chose never, rarely, sometimes, 
usually, and always with frequencies of 10, 17, 38, 31, and 8 respectively.  See appendix figure 
14 for a table of the composite frequencies for each practice and answer choice.  See appendix 
figure 15 for a graphical representation of the percentages of each response choice for each 
immunization practice. 
Assigning a quantitative weight of 1, 2, 3, 4, and 5 to responses of never, rarely, 
sometimes, usually, and always respectively, yielded the following average scores for each type 
of practice.  The average scores for screening for influenza and pneumococcal immunization 
status are 2.66 (σ = 1.24) and 2.38 (σ = 1.25) respectively, indicating the average response as 
between “rarely” and “sometimes”.  The average scores for the administration of influenza and 
pneumococcal vaccines are 1.66 (σ = 0.92) and 1.43 (σ = 0.69) respectively, indicating the 
average response as between “never” and “rarely”.  For the practice of using standing orders to 
administer vaccines, the average score is 1.55 (σ = 1.16), also correlating to an average response 
of roughly “never” to “rarely”.  Lastly, the average score for education and referral to primary 
care for vaccination is 3.10 (σ = 1.08), indicating the average response as roughly “sometimes”.  
See appendix figure 16 for a table consolidating the average response data. 
 
Support for ED Based Routine Adult Immunizations 
 Of the 104 ED directors who responded to the survey, 37 respondents reported 
supporting ED based routine adult vaccination against influenza and pneumococcus.  The 
remaining 67 respondents did not support routine ED based vaccination.  These response 
frequencies correspond to 36% and 64% of ED directors supporting vaccination and opposing 
vaccination respectively.  See appendix figure 17 for a graphical representation. 
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Perceived Barriers to ED Immunization 
 The survey respondents were asked to indicate if they agreed or disagreed with several 
common concerns as significant barriers to effective ED based vaccination programs.  The 
responses were in the form of a five point Likert scale where strongly disagree, disagree, 
neutral, agree, and strongly agree corresponded to responses of 1, 2, 3, 4, and 5 respectively.  
The concerns receiving an average score above 3.0 (neutral) were labeled as the most significant 
barriers to ED based immunization.  These concerns, in order of the level of ED director 
agreement, are that nurses do not have enough time to administer vaccines (µ = 4.22, s = 0.88), 
that patients are unable to provide an accurate vaccination history (µ = 3.94, s = 0.99), that EDs 
do not have the needed resources to store vaccinations (µ = 3.90, s = 0.99), that time pressure 
on ED physicians precludes an effective vaccination program (µ = 3.80, s = 1.05), that the lack of 
an effective ED vaccination protocol is a significant barrier to ED based vaccination (µ = 3.46, s = 
1.19), that vaccination is the sole job of primary care physicians (µ = 3.43, s = 1.11), and that an 
ED based vaccination program would be too costly (µ = 3.23, s = 1.18). 
 The remaining potential barriers to ED based vaccination, received average scores less 
than 3.0 and were labeled as less significant barriers to ED based vaccination programs.  
Continuing in descending order of average score, these potential barriers are that ED patients do 
not understand the need for vaccinations (µ = 2.94, s = 0.93), that patients do not want 
vaccinations in the ED (µ = 2.56, s = 0.87), that physicians are concerned over the adverse effects 
of vaccinations (µ = 2.46, s = 1.07), that physicians are concerned over the potential medicolegal 
liability of ED based vaccination programs (µ = 2.43, s = 1.05), that ED patients are mostly up to 
date on routine vaccinations (µ = 2.18, s = 0.82), and that vaccines are ineffective (µ = 1.44, s = 
0.60).  See appendix figure 18 and 19 for a tabular summary and graphical representation of 
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these data.  See appendix figure 20 for a percentage distribution of responses for each potential 
barrier to ED vaccination. 
 
Association with Hospital Setting 
 Chi-square tests of independence were used to test for statistical associations between 
the respondent’s hospital setting and vaccination practices, support for ED vaccination, and 
perceived barriers to ED vaccination.  Data regarding hospital setting were grouped into 
“densely populated” (includes urban and suburban) and “sparsely populated” (includes rural 
and small municipality). 
 Of the respondent hospitals, 35 (33.7%) were identified as sparsely populated and 69 
(66.3%) were identified as densely populated.  Of the hospitals located in sparsely populated 
areas, 17 (48.6%) do some screening for influenza vaccination status (defined as a response of 
sometimes, usually, or always), 15 (42.9%) do some screening for pneumococcal vaccination 
status, 5 (14.3%) do some administration of the influenza vaccine, and 1 (2.9%) does some 
administration of the pneumococcal vaccine.  Of the hospitals located in densely populated 
areas, 39 (56.5%) do some screening for influenza vaccination status, 27 (39.1%) do some 
screening for pneumococcal vaccination status, 12 (17.4%) do some administration of the 
influenza vaccine, and 5 (7.2%) do some administration of the pneumococcal vaccine.  No 
significant relationship was found between the setting description and screening for influenza 
vaccination status (X²(df = 1, N = 104) = 0.59, p = 0.533), screening for pneumococcal vaccination 
status (X²(df = 1, N = 104) = 0.13, p = 0.833), administration of the influenza vaccine (X²(df = 1, N 
= 104) = 0.164, p = 0.785), and administration of the pneumococcal vaccine (X²(df = 1, N = 104) = 
0.823, p = 0.661).  See appendix figures 21 and 22 for a cross tabulation of the data frequencies 
and percentages as well as the statistical output from the Chi-Square tests. 
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 Of the ED directors of hospitals in sparsely populated areas, 12 (34.3%) support ED 
based routine adult vaccination, while 25 (36.2%) of ED directors from densely populated areas 
support routine ED vaccination.  There was no statistically significant relationship between 
hospital setting and support for provision of ED based routine adult vaccinations (X²(df = 1, N = 
104) = 0.038, p = 1.000).  See appendix figures 23 and 24 for cross tabulation of frequencies and 
percentages and results of the statistical analysis.  Analysis of a potential link between hospital 
setting and the belief in specific factors as barriers to ED based vaccination programs resulted in 
one statistically significant relationship.  Of the 35 respondents from hospitals located in 
sparsely populated areas, 17 (48.6%) believed that patients not understanding the need for 
vaccinations is a significant barrier to ED based vaccination programs, compared to 14 (20.3%) 
of 69 respondents from hospitals in densely populated areas (X²(df = 2, N = 104) = 9.184, p = 
0.010; LR = 8.988, p = 0.011).  See appendix figures 25 and 26 for the cross tabulated 
frequencies and percentages, as well as the results from the chi-square analyses, of the other 
potential relationships. 
 
Association with ED Annual Census 
Potential relationships between the annual ED patient census and ED vaccination 
practices, support for ED vaccination, and perceived barriers to ED vaccination were tested using 
Chi-square tests of independence.  The reported results on ED patient census were grouped into 
hospitals with less than or equal to 40,000 patients per year and greater than 40,000 patients 
per year.  The data for the number of in-patient hospital beds were not tested separately, as the 
ED census data were thought to be a better predictor of the level of activity in ED and roughly 
tracked the data for in-patient beds.  See appendix figure 27 for a graphical representation of ED 
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annual census compared to in-patient beds.  There were 53 hospitals with ≤ 40,000 pts/yr, 
compared to 51 hospitals with ˃ 40,000 pts/yr. 
Of the 53 hospitals with a smaller annual ED census, 28 (52.8%) do some level of 
screening for influenza vaccination status, 20 (37.7%) do some level of screening for 
pneumococcal vaccination status, 9 (17.0%) do some administration of the influenza vaccine, 
and 3 (5.7%) do some administration of the pneumococcal vaccine.  This is compared to the 51 
hospitals with >40,000 ED patient visits per year, of which 28 (54.3%) report some level of 
screening for influenza vaccination status, 22 (43.1%) report some level of screening for 
pneumococcal vaccination status, 8 (15.7%) report some administration of the influenza vaccine, 
and 3 (5.9%) report some administration of the pneumococcal vaccine.  Chi-squared tests of 
independence showed no relationship between ED annual census and screening for influenza 
vaccination status (X²(df = 1, N = 104) = 0.045, p = 0.847), screening for pneumococcal 
vaccination status (X²(df = 1, N = 104) = 0.315, p = 0.690), administration of the influenza vaccine 
(X²(df = 1, N = 104) = 0.032, p = 1.000), and administration of the pneumococcal vaccine (X²(df = 
1, N = 104) = 0.002, p = 1.000).  See appendix figures 28 and 29 for the cross tabulation and 
statistical analysis output. 
The collected ED census data were also analyzed for a potential relationship to whether 
the respondent ED director does or does not support ED based vaccination programs, as well as 
for a relationship with the perceived barriers to ED based vaccination.  Of the hospitals with a 
small (≤ 40,000 pts) annual ED census, 21 (39.6%) support ED based vaccination programs, 
compared to 16 (31.4%) of the hospitals with a larger (> 40,000 pts) annual ED census.  
However, no statistically significant relationship between ED census and support for ED 
vaccination was found (X²(df = 1, N = 104) = 0.772, p = 0.418; LR = 0.774, p = 0.379).  See 
appendix figures 30 and 31 for the cross tabulation and statistical output.  Chi-squared analysis 
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for a relationship between the annual ED census and perceived barriers to ED based vaccination 
resulted in two statistically significant relationships.  Of the 53 hospitals with a smaller annual 
ED census, 10 (18.9%) agreed that medicolegal liability is a significant barrier to ED based adult 
vaccination programs, while 13 (24.5%) were neutral and 30 (56.6%) disagreed.  This compares 
to the 51 hospitals with larger annual ED patient censuses, where 3 (5.9%) agreed that 
medicolegal liability was a significant barrier, while 22 (43.1%) were neutral and 26 (51%) 
disagreed (X²(df = 2, N = 104) = 6.333, p = 0.042; LR = 6.565, p = 0.038).  Additionally, there was 
a statistically significant relationship between ED annual census and the belief that patients are 
up to date on vaccinations.  Of the 53 respondents from hospitals with a smaller annual ED 
patient census, 7 (13.2%), 12 (22.6%), and 34 (64.2%) respectively agreed, were neutral, or 
disagreed that patients being up to date on vaccinations is a significant barrier to ED based adult 
vaccination programs.  This compares to hospitals with larger annual ED census, were 0, 13 
(25.5%), and 38 (74.5%) respondents indicated they agreed, were neutral, or disagreed 
respectively (X²(df = 2, N = 104) = 7.226, p = 0.027; LR = 9.928, p = 0.007).  See appendix figures 
32 and 33 for the cross tabulation and statistical output. 
 
Association with Academic Status 
 The data were analyzed for possible associations between the academic status of the 
respondents’ hospital (teaching hospital v. non-teaching hospital) and vaccination related 
practices, support for ED vaccination, and agreement with potential barriers to ED based 
vaccination.  Of the 104 survey responses, 54 respondents self identified as being from non-
academic hospitals, while the remaining 50 responses were from ED directors at hospitals with 
an academic affiliation.  Within the group of respondents from non-academic hospitals, there 
were 28 (51.9%) and 22 (40.7%) respondents who report screening for influenza and 
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pneumococcal vaccination status respectively. In comparison, 28 (56%) and 20 (40%) of the 
respondents from teaching hospitals reported screening for these vaccinations respectively.  
Additionally, there were 5 (9.3%) and 3 (5.6%) of the non-academically affiliated respondents 
who report administering some level of influenza and pneumococcal vaccine in the ED 
respectively.  This compares to 12 (24%) and 3 (6%) of the respondents from academically 
affiliated hospitals who report administering some level of these vaccines respectively.  
However, no statistically significant relationship was found between any of the vaccination 
related practices and the hospital’s academic status.  The chi-squared test of independence 
between academic status and the administration of the influenza vaccine trended towards 
highlighting a possible relationship between these variables (X²(df = 1, N = 104) = 4.125, p = 
0.062; LR = 4.211, p = 0.04). See appendix figures 34 and 35 for the cross tabulation and 
statistical analysis. 
 Chi-squared tests of independence were also used to analyze for a potential relationship 
between the academic status of the respondent’s hospital and support for ED based vaccination 
programs, as well as the belief in specific barriers to these programs.  Seventeen (31.5%) of the 
54 respondents from hospitals with no academic affiliation support ED based adult vaccination, 
while 20 (40%) of the 50 respondents from academic hospitals are in support of ED based 
vaccination programs.  However, no statistically significant relationship between hospital 
academic status and support for ED based vaccination was found (X²(df = 1, N = 104) = 0.822, p = 
0.416).  See appendix figures 36 and 37 for the cross tabulation and statistical analysis output 
for this comparison.  Additionally, no statistically significant relationships between hospital 
academic status and belief in specific barriers to ED based vaccination.  However, one analysis 
showed a trend towards statistical significance where 37 (68.5%) of respondents from non-
academically affiliated hospitals agreed that vaccination is solely the job of primary care 
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physicians, compared to 24 (48%) of respondents at academically affiliated hospitals (X²(df = 2, 
N = 104) = 4.954, p = 0.084; LR = 5.003, p = 0.082).  See appendix figures 38 and 39 for the 
respective cross tabulation and statistical output. 
   
Association with Administration of Influenza Vaccine 
 Out of 104 respondents, 17 reported administering the influenza vaccine in the ED at a 
frequency of sometimes, usually, or always, while 87 reported administering it rarely or never.  
Of the 87 ED directors whose ED’s do not administer the influenza vaccine, 25 (28.7%) support 
ED based adult vaccination programs.  In comparison, 12 (70.6%) out of the 17 who do report 
some level of ED based influenza vaccine support routine adult immunization in the ED.  The chi-
squared test of independence demonstrated a statistically significant relationship between 
administration of some level of influenza vaccine in the ED and support for ED based routine 
vaccination programs (X²(df = 1, N = 104) = 10.869, p = 0.002; LR = 10.764, p = 0.001).  See 
appendix figures 40 and 41 for the respective cross tabulation and statistical output. 
 The data were analyzed for potential relationships between the administration of some 
level of influenza vaccinations in the ED and belief in specific barriers to immunization, of which 
three statistically significant relationships were found.  Out of the 87 respondents who report 
their EDs do not administer the influenza vaccine on any significant level, 55 (63.2%) agreed with 
the statement that administration of routine adult vaccinations is the sole responsibility of 
primary care physicians, while 18 (20.7%) were neutral, and 14 (16.1%) disagreed.  
Comparatively, of the 17 respondents who do administer the influenza vaccine on a significant 
level, 6 (35.3%) agreed, 2 (11.8%) were neutral, and 9 (52.9%) disagreed (X²(df = 2, N = 104) = 
11.211, p = 0.004; LR = 9.625, p = 0.008).  Seventy-eight (89.7%) of the respondents who do not 
administer the influenza vaccine agreed that nursing time constraints is a significant barrier to 
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ED based vaccination programs, while 7 (8.0%) were neutral, and 2 (2.3%) disagreed.  In 
comparison, 13 (76.5%) of the respondents who administer some level of influenza vaccine in 
the ED agreed that nursing time constraints were a significant barrier, while 4 (23.5%) disagreed 
(X²(df = 2, N = 104) = 12.761, p = 0.002; LR = 9.625, p = 0.008).  Lastly, of the 87 ED directors who 
deny any significant level of influenza vaccine administration in their EDs, 13 (14.9%) agreed that 
medicolegal liability was a significant barrier to ED based adult vaccination programs, while 24 
(27.6%) were neutral, and 50 (57.5%) disagreed.  Conversely, none of the 17 respondents who 
report administering the influenza vaccine agreed with this potential barrier, 11 (64.7%) were 
neutral, and 6 (35.3%) disagreed (X²(df = 2, N = 104) = 9.662, p = 0.008; LR = 10.926, p = 0.004).  
See appendix figures 42 and 43 for the cross tabulation and statistical output from the chi-
squared tests of independence.   
  
Association with Administration of Pneumococcal Vaccine 
 Of all the respondents, only 6 reported administering the pneumococcal vaccine in the 
ED at some significant level, while the remaining 98 reported rarely or never administering the 
vaccine.  Of the six respondents who do administer the vaccine, 4 (66.7%) report supporting the 
administration of routine adult vaccinations in the ED, compared to 33 (33.7%) of the 98 
respondents that do not administer the pneumococcal vaccine in the ED.  The chi-square test of 
independence did not demonstrate a statistically significant difference between the two groups 
in relation to support for ED vaccination programs (X²(df = 1, N = 104) = 2.685, p = 0.183).  See 
appendix figures 45 and 46 for the respective cross tabulation and statistical output. 
 The data were analyzed for potential relationships between the administration of some 
level of pneumococcal vaccinations in the ED and belief in specific barriers to immunization, of 
which three statistically significant relationships were found.  Out of the 98 respondents who 
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report their EDs do not administer the pneumococcal vaccine on any significant level, 87 (88.8%) 
agree that the time constraint placed on nurses is a significant barrier to the administration of 
ED based routine vaccinations, compared to 7 (7.1%) who were neutral and 4 (4.1%) who 
disagreed.  Of the 6 respondents who administer the pneumococcal vaccine on some level, 4 
(66.7%) agreed that nurse time constraints were a significant barrier while the remaining 2 
respondents (33.3%) disagreed.  The chi-square test of independence showed a statistically 
significant relationship between these variables (X²(df = 2, N = 104) = 9.13, p = 0.01; LR = 5.42, p 
= 0.066).  Next, 78 (79.6%) respondents who report not administering the pneumococcal vaccine 
in the ED agree that the need for resources to store the vaccinations is a significant barrier to ED 
based vaccination programs, while 12 (12.2%) were neutral and 8 (8.2%) disagreed.  Of the 
respondents who do administer the pneumococcal vaccine in the ED, only 1 (16.7%) agreed that 
the need for resources to store the vaccine is a significant barrier, while 2 (33.3%) were neutral 
and 3 (50%) disagreed (X²(df = 2, N = 104) = 9.13, p = 0.01; LR = 5.42, p = 0.066).  Lastly, of the 98 
ED directors who do not administer the pneumococcal vaccine in their EDs, 49 (50%) agree that 
cost is a significant barrier to ED based vaccination programs, while 21 (21.4%) are neutral and 
28 (28.6%) disagree.  Of those that administer the pneumococcal vaccine, none agree that cost 
is a significant barrier, and 2 (33.3%) are neutral while 4 (66.7%) disagree that cost is a 
significant barrier to ED based vaccination (X²(df = 2, N = 104) = 6.03, p = 0.049; LR = 8.18, p = 
0.017).  See appendix figures 46 and 47 for the cross tabulation and statistical output from the 
chi-squared tests of independence.   
 
Association with Support for ED Vaccination 
 Of the 104 respondents, 37 support ED based vaccination programs and 67 do not 
support these programs.  Comparing the responses of these two subgroups to the questions 
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assessing agreement with various potential barriers for ED vaccination programs, six statistically 
significant relationships were found.  First, of the 67 respondents who do not support ED 
vaccination, 47 (70.1%) agree that belief that vaccination is the sole job of primary care is a 
significant barrier, while 15 (22.4%) are neutral, and 5 (7.5%) disagree.  This compares to the 37 
respondents who do support ED vaccination, where 14 (37.8%) agree, 5 (13.5%) are neutral, and 
18 (48.6%) disagree (X²(df = 2, N = 104) = 23.5, p = 0.000; LR = 23.1, p = 0.000).  Fifty-four 
(80.6%) of the respondents who do not support ED vaccination agree that physician time 
constraints are a significant barrier, while 7 (10.4%) are neutral and 6 (9%) disagree.   In 
comparison, 20 (54.1%) of the 37 respondents who support ED vaccination agree that physician 
time constraints are a significant barrier, while 8 (21.6%) are neutral and 9 (24.3%) disagree 
(X²(df = 2, N = 104) = 8.327, p = 0.016; LR = 8.116, p = 0.017).  Sixty-five (97%) of those who do 
not support ED vaccination programs agree that nurse time constraints are a significant barrier, 
while 2 (3%) are neutral and none disagree.  On the other hand, 26 (70.3%) of the respondents 
who support vaccination agree, along with 5 (13.5%) who are neutral and 6 (16.2%) who 
disagree (X²(df = 2, N = 104) = 16.74, p = 0.000; LR = 18.14, p = 0.000).  Fifty-six (83.6%) of the 
respondents who do not support ED vaccination agree that the need for additional resources to 
store vaccines is a significant barrier, while 6 (9%) are neutral and 5 (7.5%) disagree.  In 
comparison, of the 37 respondents who support ED vaccination, 23 (62.2%) agree, 8 (21.6%) are 
neutral, and 6 (16.2%) disagree (X²(df = 2, N = 104) = 6.007, p = 0.05; LR = 5.816, p = 0.055).  
Thirteen (19.4%) of the 67 respondents who do not support ED based vaccination agree that 
medicolegal liability is a significant barrier to ED vaccination programs, while 22 (32.8%) are 
neutral, and 32 (47.8%) disagree.  On the other hand, of the 37 respondents who support ED 
vaccination, none agree that medicolegal liability is a significant barrier, while 13 (35.1%) are 
neutral, and 24 (64.9%) disagree (X²(df = 2, N = 104) = 8.512, p = 0.014; LR = 12.73, p = 0.002).  
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Lastly, 20 (29.9%) of respondents who do not support ED vaccination agree that patients not 
understanding the need for vaccinations is a significant barrier to ED vaccination programs, 
while 32 (47.8%) are neutral, and 15 (22.4%) disagree.  Comparatively, of the respondents who 
support ED vaccination, 11 (29.7%) agree, while 9 (24.3%) are neutral and 17 (45.9%) disagree 
(X²(df = 2, N = 104) = 7.621, p = 0.022; LR = 7.68, p = 0.021).  See appendix figures 48 and 49 for 
the full cross tabulation and statistical output. 
 
Comments 
 ED directors were also solicited for comments pertaining to the topic of ED 
based routine adult vaccination against influenza and pneumococcus.  Of the 104 
respondent physicians, 35 chose to provide a comment.  See appendix figure 50 for the 
aggregated collection of comments. 
 
  
45 
 
DISCUSSION 
Current Practices 
 The collected data indicate that roughly 43% and 35% of ED directors work in hospitals 
that administer some level of ED based influenza and pneumococcal vaccinations respectively.  
These frequencies are unexpectedly high compared to anecdotal experience, but when the data 
are adjusted to exclude the responses where vaccinations were “rarely” given then the rates 
become 16.3% and 5.8% respectively.  From the sampled population, these rates are likely to be 
the most accurate for the generalization to the population of EDs as a whole, and are correlated 
with antidotal experience of few EDs routinely administering vaccinations.  These rates are still 
higher than expected, as it was hypothesized that less than 5% of the surveyed population 
would report any significant level of ED vaccination administration. 
 Looking at the average scores for the vaccine related practices, the majority of 
respondents indicate screening for influenza and pneumococcal vaccination status with a 
frequency averaging between “rarely” and “sometimes”, while the administration of these 
vaccines averages between “never” and “rarely”.  The average response for referral to primary 
care was roughly “sometimes”.  Thus, it can be extrapolated that the most common practice 
patterns are not screening for and not administering routine adult vaccinations, followed by 
screening for vaccination status and referral to primary care for vaccine administration.  
Unfortunately, referral to primary care from the ED for routine health has been seen to be 
largely ineffective at increasing vaccination rates. (83)  Finally, the data analysis indicates there 
may be a relationship between working at a teaching hospital and the administration of the 
influenza vaccine, where EDs at teaching hospitals may be more likely to administer influenza 
vaccinations.  The chi-squared test of independence resulted in a value of 4.125 (p = 0.062), 
which would likely become statistically significant with an increase in the power of the sample, 
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while the analysis resulted in an LR of 4.211 (p = 0.04).  There was no significant relationship 
between teaching hospital status and the administration of the pneumococcal vaccine. 
 
Support for ED Vaccination 
 While the results estimating the frequency of ED based routine adult vaccination 
suggests that this practice is not very prevalent, the collected data indicate that 36% of 
respondents support ED based routine vaccination against influenza and pneumococcus.  There 
are several possible explanations for this suggested discrepancy in the results.  First, it simply 
may be the case that many more practitioners support providing these vaccinations, but simply 
do not routinely provide them due to an existing precedent of non-vaccination at their 
institution.  While the survey respondents were composed of the ED physician leadership at the 
various surveyed hospitals, there may be significant opposition from other practitioners, 
administration, or existing precedents.  As expected, the data analysis did show a strongly 
statistically significant relationship between supporting ED based vaccination and routinely 
administering the influenza vaccine.  There is likely an experiential bias partially explaining these 
results, in that ED directors working at EDs that provide routine vaccinations have experienced 
these programs and can more adequately assess the effect the program has on the ED and the 
barriers or lack thereof to these programs.  However, there were also many responses where 
the respondent indicated support for ED based vaccination, yet indicated that their ED does not 
provide a significant level of ED based vaccinations.  The converse situation was also frequent, in 
which an ED director indicated opposition to ED vaccination, but indicated that their ED 
provided a significant number of ED based vaccinations.  These apparent contradictions may be 
due to the autonomy for practice related decisions that clinicians often enjoy, in which some 
clinicians who support ED vaccination can choose to administer the vaccines while others may 
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not.  Finally, some ED directors may wish to administer vaccines but feel limited from doing so 
by the various potential barriers to vaccination they identify.  For example, an ED director may 
wish to start an ED based vaccination program, but is precluded from doing so by lack of support 
from the nursing staff who believe that it would be a significant and unjustified burden to their 
clinical responsibilities.  Overcoming perceived opposition from various groups in favor of an 
experiential learning approach, would likely be a significant but necessary challenge for any new 
ED based vaccination program. 
 
Barriers to ED Vaccination 
 Of the potential barriers to ED based vaccination programs that were examined, the 
most significant barriers in order of significance are as follows: time pressure on nurses, patients 
inability to provide an accurate vaccination history, lack of needed resources to store 
vaccinations, time pressure on ED physicians, lack of an ED vaccination protocol, belief that 
vaccination is the sole job of primary care physicians, and the prohibitively high cost of a 
vaccination program.   
Time pressure on nurses was the most significant barrier identified and likely represents 
the most limiting factor for the success of an ED based vaccination programs.  Slobodkin et al 
found that ED vaccination related efforts took roughly four minutes per patient and were not 
associated with any delays in treatment.  (51)  However, EDs often experience an ebb and flow 
of patient volume and acuity, and while there may be times when vaccination is very feasible 
task for the nurses to engage in, there are clearly periods when the time pressure and acuity of 
patients prevents all but the efforts needed to treat the acute illness from being accomplished.  
Physician time pressure was also identified as a barrier to ED vaccination, although on average it 
was indicted as less significant barrier than time pressure on nurses.  The physician time needed 
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for vaccination related efforts is largely reduced by the use of standing orders for screening and 
administration of vaccines, which this study indicates are used on an infrequent basis with the 
average response being between “never” and “rarely”. (86, 87)  Not surprisingly, the data 
analysis indicated that there was a statistically significant relationship where respondents who 
oppose ED based vaccination and work in EDs that do not routinely provide influenza and 
pneumococcal vaccines were more likely to believe that nurse time constraints is a significant 
barrier to ED based vaccination programs.  It was also found that respondents who do not 
support ED based vaccination were more likely to believe that physician time constraints are a 
significant barrier to vaccination programs as well.  Taken together, it can be concluded that 
time constraints on staff performing vaccination related activities is believed to be the most 
significant barrier to implementing a successful ED based vaccination program.  It was 
hypothesized that the hospitals with larger annual ED censuses would represent the busier EDs, 
where respondents would be more likely to believe that time constraints on nurses is a 
significant barrier to ED vaccination programs.  While the results trended towards a significant 
relationship, the chi-squared test of independence did not show a statistically significant value 
at a 95% confidence interval (X² = 4.190, p = 0.123). 
The second most important factor indicated as a barrier to ED based vaccination was the 
patient’s inability to provide an accurate vaccination history.  It can be inferred that the concern 
would be that patients would provide inaccurate histories that would cause patients who have 
already been vaccinated to be re-vaccinated or that patients who are un-vaccinated would 
remain un-vaccinated due to their inability to provide a clear history.  This argument against ED 
vaccination is largely proven insignificant by the available literature.  First, self-reported 
vaccination status as a tool to determine vaccination status has a sensitivity in the high 90’s and 
a specificity in the 70’s, with at least a 70% PPV as validated against the patient’s medical 
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record. (84, 85)  Additionally, with a minimal risk for adverse effects from re-vaccination, the 
ACIP recommends acceptance of the patient self-report as proof of vaccination status. (7)  An 
important area for future investigation would be to determine if ED based vaccination programs 
have a significant repeat vaccination rate and the effect this has on the cost-effectiveness of 
immunization programs. 
The lack of needed resources to store vaccines was the third most important identified 
barrier to ED based vaccination programs.  Additionally, an estimated high cost of ED 
vaccination programs was also identified as a significant barrier.  The need for more funding and 
resources to provide a specific intervention is often a concern for the ED leadership and 
administration of a hospital.  Administration of the influenza vaccine has been found to be cost-
effective, and administration of the pneumococcal vaccine is one of the few interventions that 
has been found to be cost-saving. (14, 18, 69-71)  However, these studies generally determine 
the cost to community as a whole as opposed to the institution providing the intervention.  
These studies would likely need to be conducted before hospital administration is ready to 
financially support an ED vaccination initiative.  Several studies have determined that an ED 
vaccination program will likely reduce costly hospitalizations in patients that would return to the 
same hospital with a vaccine preventable illness.  (50, 51, 54, 62)  There was a statistically 
significant relationship between opposition to ED based vaccination programs and the belief 
that needing resources to store vaccines is a significant barrier to these programs.  The data 
analysis also showed a statistically significant relationship in which respondents who routinely 
administered the pneumococcal vaccine were less likely to believe that needing additional 
resources to store vaccines or the cost of a vaccination program were significant barriers to ED 
based vaccination programs.  As the influenza vaccine is administered more commonly in the ED 
compared to the pneumococcal vaccination, the few EDs that are routinely administering the 
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pneumococcal vaccine likely have the most experience with ED based vaccination programs with 
the ability to analyze the financial ramifications of these programs. 
Another important barrier to ED vaccination programs that was identified by 
respondents was the lack of an ED vaccination protocol.  While this may prevent the 
administration of vaccines in some hospitals, it is unlikely that this is a critical road block to the 
establishment of ED vaccination programs in EDs with practitioners that support these 
programs. 
 The belief that vaccination is the sole responsibility of primary care providers was 
identified as one of the significant barriers to ED based vaccination programs.  As expected, this 
is a common belief in respondents that do not support ED based vaccination.  The chi-squared 
analysis identified a statistically significant relationship exists between supporting ED 
vaccination programs, administering the influenza vaccination on a significant level, and 
disagreeing with the statement that vaccination is the sole responsibility of primary care.  The 
data analysis did not demonstrate any difference in the agreement or disagreement with this 
potential barrier to ED based vaccination between hospitals with different annual ED censuses 
or demographic characteristics.  While an ideal healthcare system would place vaccination as 
the sole responsibility of primary care, it is widely known that many patients do not have 
primary care or inappropriately use the ED for primary care.  Referral to primary care from the 
ED for vaccinations has proven to be largely unsuccessful. (83)  Thus, in can be reasoned that 
one of three outcomes will occur: development of more successful methods for primary care 
referral, acceptance that patients will remain un-vaccinated despite medical indication, or 
acceptance of more ED physicians that some aspects of primary care need to be delivered in the 
ED for the current lack of a better alternative. 
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 While the other tested barriers to ED based vaccination programs were not on average 
identified as significant barriers to vaccination, several interesting associations emerged from 
the data analysis.  Respondents from hospitals with a smaller annual ED census, those that 
oppose ED based vaccination, and those that do not administer a significant level of influenza 
vaccination were all more likely to agree that medicolegal liability is a significant barrier to ED 
based vaccination programs.  Additionally, respondents who oppose ED based vaccination and 
respondents from hospitals in densely populated areas were found to be statistically more likely 
to believe that their patients’ inability to understand the need for vaccinations is a significant 
barrier to ED based vaccination programs.  Finally, respondents working at hospitals with a 
smaller annual ED census were found to be statistically more likely to believe that their patients 
being up-to-date on vaccinations is a barrier to ED based vaccination programs. 
 
Limitations & Future Directions 
 Because of the diverse nature of different ED settings and the differing experiences of 
the ED directors, it is difficult to use a simple survey to ascertain the complete spectrum of 
perceptions regarding a particular subject due to the large number of confounding variables.  
One limitation of this study is that it simplifies and categorizes the potential barriers to ED based 
vaccination into what was thought to be a largely comprehensive list of barriers; however, 
multiple permutations and extenuating circumstances likely exist within and beyond this list.  
For instance, ED directors may see time as a significant barrier to vaccination when the ED is 
crowded and busy, but might support vaccination efforts during off-peak periods.  Additionally, 
vaccination may be deemed acceptable by certain ED directors in times of outbreaks, or for 
special patient populations.  The study did not contain an appropriate mechanism to 
appropriately survey these possibilities.  Additionally, this study was aimed at ascertaining the 
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baseline perceptions of the ED directors regarding vaccination practices.  A significant number of 
ED directors are likely not familiar with the existing literature regarding ED based vaccination, 
and the survey did not ascertain if the ED director had previously entertained the idea of 
offering ED based vaccinations.  Examining the potential for shifting perceptions of ED directors 
in response to increased awareness of the existing literature regarding studies testing the 
feasibility of ED based vaccination is a potential avenue for future research. 
 Several flaws with the design of the study ended up limiting the applicability of the 
conclusions.  While the study was aimed to determine a census opinion from the EDD in the 
states included in the study, the low response rate relative to the total number of EDDs resulted 
in an improperly randomized sample being drawn.  Additionally, the response bias that is 
typically inherent in studies utilizing survey responses also limits the applicability of the results, 
as EDDs with very positive or very negative opinions are more likely to respond than other EDDs 
without similarly strong opinions.  The combination of a poorly randomized sample from a 
limited region of the United States and an inherent response bias limits the generalization of the 
results to the entire population of EDDs. 
The relatively small number of EDDs responding to the survey also significantly lowered 
the statistical power of the analysis.  Aside from sampling a larger population of EDDs, another 
means to increase the statistical power is to use a study design incorporating a likelihood ratio 
as the primary means for testing statistically significant relationships.  A survey design that does 
not necessitate collapsing certain data would facilitate also facilitate more power for data 
analysis. While roughly 26% of all adult ED directors in the northeast responded to the survey, 
the overall subject population is inherently small.  ED directors were targeted for the study as 
this group was thought to represent the main “decision-makers” regarding ED medical practices.  
The study may have gained the needed power to bring out more subtle associations in the data 
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if the target population had been expanded to include all EPs.  The process of making any 
change made to ED medical policy would likely involve a collective majority of the ED physicians 
practicing at that site, as well as various other stake holders.  An appropriate follow-up study 
could investigate the opinions of ED physicians at large, as well as other groups including nurses 
and administrative personnel.  These other stake holder groups will likely have significantly 
different priorities than ED physicians, such as increased pressure for nurses and concerns about 
cost and cost savings for administrative personnel. 
 The study was useful for ascertaining an estimate of the current frequency of ED 
vaccination related practices.  One limitation of this aspect of the study is that only qualitative 
estimates were sought (never, rarely, sometimes, often, and always) and no quantitative data 
were collected.  This decision was based on the belief that ED directors would not know these 
specific frequencies without doing some needed research and that asking questions requiring 
significant work on behalf of the respondent ED director would significantly reduce the survey 
response rate.  This study provided evidence that more influenza and pneumococcal vaccines 
are being administered than previously believed based on antidotal observation.  However, 
more supporting evidence in regards to quantitative estimates is needed to solidify this 
conclusion. 
 
Conclusions 
Currently, ED based vaccination of adults against influenza and pneumococcus exists in 
various states, ranging from fully implemented programs to EDs with no vaccination efforts.  The 
debate regarding the appropriateness of ED based vaccination will likely continue far into the 
future, as opinions about the role of public health concerns in the future of emergency medicine 
are diverse and often divergent.  Vaccination is inherently a function of primary care physicians, 
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yet in the current state of affairs, many ED patients go without primary care (or receive it in the 
ED).  The medical community largely agrees that the high risk group of patients that frequents 
the ED needs to be vaccinated, but the best means to provide these vaccinations is far from 
consensus.  There is no one size fits all solution and programs tailored specifically for various 
communities will likely have the greatest success.  It is up to the medical leaders of these 
communities to determine the appropriate role for the ED in these efforts. 
While an ideal health care system would employ primary care for all healthcare 
functions related to disease prevention, immunization included, it is clear that the current 
system is far from this ideal goal.  While system level changes are needed to move closer to a 
more ideal operating model, in the interim the under vaccinated and at risk population of 
patients that frequent hospital emergency departments receive a sub-optimal level of 
preventive medical care.  Emergency departments are frequently over-burdened by high 
volumes of patients and little resources; however, they are uniquely positioned to be arguably 
one of the most effective sites for reaching a large percentage of the at risk and under 
vaccinated population.  Coordinated vaccination efforts utilizing public health resources and the 
ED setting would be a highly effective interim solution to close the gap between the CDC’s 
vaccination goals and current vaccination levels.  The long term solution rests in refining our 
health delivery systems and increasing the access to primary care. 
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APPENDIX 
Figure 1: Electronic survey administered to ED directors. 
Page 1: Informed Consent 
The following survey is part of an HIC approved study from the Department of 
Emergency Medicine at the Yale University School of Medicine (HIC 
#09070054971243). The purpose of the study is to evaluate the attitudes and 
perceptions of Emergency Department Directors regarding routine adult 
immunization against influenza and pneumococcal disease in the Emergency 
Department. The survey takes approximately 5 minutes to complete. All 
responses will remain anonymous. The four digit survey code supplied in the 
e-mail is used to track responses, and it will not be used to link specific survey 
data to particular hospitals or individuals. Your e-mail address and contact 
information will not be used for any other purposes other than the completion 
of this survey. Thank you in advance for your participation. 
 
Please enter the 4 digit survey code supplied in the e-mail if you agree to participate in 
the study. ______ 
 
Page 2: Hospital & ED Information 
Please complete the following questions regarding characteristics of your 
hospital/ED to the best of your ability. 
 
1. Please characterize the demographic setting in which the hospital where you work 
is located. 
Rural 
Small Municipality 
Suburban 
Urban 
 
2. Is the hospital at which you work considered public (government run or majority 
publicly funded) or private? 
63 
 
 Private 
Public (non-VA) 
VA 
Unsure 
 
3. What is the teaching status of the hospital at which you work? 
Teaching/Academic 
Non-Teaching/Non-academic 
 
4. Indicate the approximate combined annual patient census for all parts of your ED 
(ED patients per year) including any separate acute care section if such exists. Also, 
please indicate the number of in-patient beds of the hospital for which you work. 
(Answers should be in numerical digits without comas.) 
Annual ED patient census: ____ 
 
Hospital In-patient beds: ____ 
 
 
Page 3: Immunization Practices in the ED 
Please estimate the frequency of which the following activities occur in your ED for 
the treatment of non-admitted ED patients only. 
 Never Rarely Sometimes Usually Always 
Screening for influenza immunization 
status 
     
Screening for pneumococcal 
immunization status 
     
Administration of influenza vaccine 
when indicated 
     
Administration of pneumococcal vaccine 
when indicated 
     
Use of standing orders for 
administration of vaccines 
     
Education and referral to primary care 
provider for administration of needed 
immunizations 
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Page 4: Barriers to ED Immunization 
1. Do you support the administration of routine adult immunizations against influenza 
and pneumococcus in the emergency department? 
Yes 
No 
 
2. Please indicate your level of agreement with the following factors as barriers to ED 
based routine adult immunization against influenza and pneumococcal disease 
specifically in regards to your ED and personal practice beliefs. 
 
 Strongly 
Agree 
Agree Neutral Disagree Strongly 
Disagree 
Belief that routine immunization is the sole 
responsibility of primary care physicians 
     
Concern over time constraints on physicians      
Concern over time constraints on nurses      
Need for additional resources to store and 
administer immunizations 
     
Concern that patients are unable to provide 
an accurate immunization history 
     
Concern over adverse effects of 
immunizations 
     
Concern regarding medicolegal liability      
Concern over cost of providing routine 
immunizations 
     
Concern that patients do not want routine 
immunizations to be administered in the ED 
     
Concern that patients do not understand 
the need for routine immunizations 
     
Concern that influenza and pneumococcal 
vaccinations are ineffective 
     
Lack of structured immunization screening 
and administration protocol 
     
Belief that the patient population at your 
ED is mostly up-to-date on immunizations 
     
 
Page 5: Additional Comments 
Please provide any additional comments you have regarding routine adult 
immunization against influenza and pneumococcal disease in the ED. (Optional) 
______________________________________________________________________________ 
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Figure 2:  Chi-Squared Tests of Independence 
  
Variable 1 Variable 2
ED Census Screening for Influen Vac
" Screening for Pnemo Vac
" Admin of Influen Vac
" Admin of Pneumo Vac
" Support for ED Vac
" Barriers to Immunization
   - Job of Primary Care
   - Physician Time
   - Nurse Time
   - Resources to Store
   - Unable to Provide History
   - Adverse Effects
   - Mediolegal Liabilty
   - Cost
   - Pts Don't Want
   - Pts Don't Understand Need
   - Vaccine Ineffective
   - Lack of Protocol
   - Pts are Up to Date
Hospital Setting Screening for Influen Vac
" Screening for Pnemo Vac
" Admin of Influen Vac
" Admin of Pneumo Vac
" Support for ED Vac
" Barriers to Immunization
Academic Status Screening for Influen Vac
" Screening for Pnemo Vac
" Admin of Influen Vac
" Admin of Pneumo Vac
" Support for ED Vac
" Barriers to Immunization
Admin of Infleun Vac Support for ED Vac
" Barriers to Immunization
Admin of Pneumo Vac Support for ED Vac
" Barriers to Immunization
66 
 
Figure 3: ED directors identified, contacted, and responded. 
 
 
Figure 4: ED directors identified, contacted, and responded by state. 
 
 
Identified Contacted Responded Response Rate
CT 31 25 16 64.0%
MA 75 57 29 50.9%
MN 36 19 8 42.1%
NH 26 14 7 50.0%
NY 206 86 33 38.4%
RI 11 6 4 66.7%
VT 14 11 7 63.6%
Total 399 218 104 47.7%
Emergency Department Directors…
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Figure 5: State by state contribution to total collected results. 
 
 
Figure 6: Respondent Hospital Setting (by frequency) 
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Figure 7: Respondent Hospital Setting (by percentage) 
 
 
Figure 8: Respondent Hospital Funding (by frequency) 
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Figure 9: Respondent Hospital Funding (by percentage) 
 
 
Figure 10: Respondent Hospital Academic Status (by percentage) 
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Figure 11: Relationship between Setting and Number of In-Patient Beds 
 
 
Figure 12: Relationship between Setting and Annual ED Census 
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Figure 13: In-Patient Beds and ED Census by Teaching Status 
 
 
Figure 14: Immunization Practices (by frequency) 
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Influenza
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of Influenza
Administration of 
Pneumococcal
Use of Standing 
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Education and 
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Never 24 32 59 68 81 10
Rarely 24 30 28 30 5 17
Sometimes 26 20 11 3 8 38
Usually 23 15 5 3 4 31
Always 7 7 1 0 6 8
Total 104 104 104 104 104 104
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Figure 15: Immunization Practices (by percentage) 
 
 
Figure 16: Average Responses for Immunization Practices 
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Figure 17: Support for ED Based Routine Adult Vaccination 
 
 
Figure 18: Evaluation of Potential Barriers to ED Based Routine Vaccination 
 
Rank of Percieved 
Importance
Potential Barrier to ED 
Vaccination
Average 
Score Std Dev
1 Nurse Time 4.22 0.88
2 Unable to Provide History 3.94 0.99
3 Resources to Store 3.90 0.99
4 Physician Time 3.80 1.05
5 Lack of Protocol 3.46 1.19
6 Job of Primary Care 3.43 1.11
7 Cost 3.23 1.18
8 Pts Don't Understand Need 2.94 0.93
9 Pts Don't Want 2.56 0.87
10 Adverse Effects 2.46 1.07
11 Medicolegal Liability 2.43 1.05
12 Up to Date 2.18 0.82
13 Vacc Ineffective 1.44 0.60
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Figure 19: Average Scores of Potential Barriers to ED Vaccination 
 
Figure 20: Percentage Distribution of Responses to Barriers to Vaccination 
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Figure 21: Cross tabulation: Setting v. Vaccination Practices 
 
Figure 22: Chi-Square analysis: Setting v. Vaccination Practices 
 
Total Total Total Total
No Yes No Yes No Yes No Yes
Count 18 17 35 20 15 35 30 5 35 34 1 35
% within 
Setting 51.4% 48.6% 100.0% 57.1% 42.9% 100.0% 85.7% 14.3% 100.0% 97.1% 2.9% 100.0%
% within 
Screening 
or Admin
37.5% 30.4% 33.7% 32.3% 35.7% 33.7% 34.5% 29.4% 33.7% 34.7% 16.7% 33.7%
% of Total 17.3% 16.3% 33.7% 19.2% 14.4% 33.7% 28.8% 4.8% 33.7% 32.7% 1.0% 33.7%
Count 30 39 69 42 27 69 57 12 69 64 5 69
% within 
Setting 43.5% 56.5% 100.0% 60.9% 39.1% 100.0% 82.6% 17.4% 100.0% 92.8% 7.2% 100.0%
% within 
Screening 
or Admin
62.5% 69.6% 66.3% 67.7% 64.3% 66.3% 65.5% 70.6% 66.3% 65.3% 83.3% 66.3%
% of Total 28.8% 37.5% 66.3% 40.4% 26.0% 66.3% 54.8% 11.5% 66.3% 61.5% 4.8% 66.3%
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Likelihood Ratio 0.921 1 0.337   
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Figure 23: Cross tabulation: Setting v. Support for ED Vaccination 
 
Figure 24: Chi-Square analysis: Setting v. Support for ED Vaccination 
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Count 23 12 35
% within 
Setting 65.7% 34.3% 100.0%
% within 
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Setting 63.8% 36.2% 100.0%
% within 
Support 65.7% 67.6% 66.3%
% of Total 42.3% 24.0% 66.3%
Count 67 37 104
% within 
Setting 64.4% 35.6% 100.0%
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Support 100.0% 100.0% 100.0%
% of Total 64.4% 35.6% 100.0%
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Pearson Chi-Square 0.038 1 0.845   
Continuity Correction 0 1 1   
Likelihood Ratio 0.038 1 0.844   
Fisher's Exact Test
   1 0.511
Linear-by-Linear Assoc 0.038 1 0.845   
N of Valid Cases 104     
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Figure 25: Cross tabulation: Setting v. Barriers to ED Vaccination 
  
Disagree Neutral Agree Disagree Neutral Agree Disagree Neutral Agree Disagree Neutral Agree Disagree Neutral Agree
Count 7 7 21 35 7 6 22 35 2 3 30 35 6 3 26 35 4 4 27 35
% within 
Setting 20.0% 20.0% 60.0% 100.0% 20.0% 17.1% 62.9% 100.0% 5.7% 8.6% 85.7% 100.0% 17.1% 8.6% 74.3% 100.0% 11.4% 11.4% 77.1% 100.0%
% within 
Potential 
Barrier
30.4% 35.0% 34.4% 33.7% 46.7% 40.0% 29.7% 33.7% 33.3% 42.9% 33.0% 33.7% 54.5% 21.4% 32.9% 33.7% 28.6% 33.3% 34.6% 33.7%
% of Total 6.7% 6.7% 20.2% 33.7% 6.7% 5.8% 21.2% 33.7% 1.9% 2.9% 28.8% 33.7% 5.8% 2.9% 25.0% 33.7% 3.8% 3.8% 26.0% 33.7%
Count 16 13 40 69 8 9 52 69 4 4 61 69 5 11 53 69 10 8 51 69
% within 
Setting 23.2% 18.8% 58.0% 100.0% 11.6% 13.0% 75.4% 100.0% 5.8% 5.8% 88.4% 100.0% 7.2% 15.9% 76.8% 100.0% 14.5% 11.6% 73.9% 100.0%
% within 
Potential 
Barrier
69.6% 65.0% 65.6% 66.3% 53.3% 60.0% 70.3% 66.3% 66.7% 57.1% 67.0% 66.3% 45.5% 78.6% 67.1% 66.3% 71.4% 66.7% 65.4% 66.3%
% of Total 15.4% 12.5% 38.5% 66.3% 7.7% 8.7% 50.0% 66.3% 3.8% 3.8% 58.7% 66.3% 4.8% 10.6% 51.0% 66.3% 9.6% 7.7% 49.0% 66.3%
Count 23 20 61 104 15 15 74 104 6 7 91 104 11 14 79 104 14 12 78 104
% within 
Setting 22.1% 19.2% 58.7% 100.0% 14.4% 14.4% 71.2% 100.0% 5.8% 6.7% 87.5% 100.0% 10.6% 13.5% 76.0% 100.0% 13.5% 11.5% 75.0% 100.0%
% within 
Potential 
Barrier
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
% of Total 22.1% 19.2% 58.7% 100.0% 14.4% 14.4% 71.2% 100.0% 5.8% 6.7% 87.5% 100.0% 10.6% 13.5% 76.0% 100.0% 13.5% 11.5% 75.0% 100.0%
Disagree Neutral Agree Disagree Neutral Agree Disagree Neutral Agree Disagree Neutral Agree Disagree Neutral Agree
Count 20 8 7 35 19 10 6 35 10 6 19 35 16 15 4 35 9 9 17 35
% within 
Setting 57.1% 22.9% 20.0% 100.0% 54.3% 28.6% 17.1% 100.0% 28.6% 17.1% 54.3% 100.0% 45.7% 42.9% 11.4% 100.0% 25.7% 25.7% 48.6% 100.0%
% within 
Potential 
Barrier
34.5% 28.6% 38.9% 33.7% 33.9% 28.6% 46.2% 33.7% 31.3% 26.1% 38.8% 33.7% 33.3% 33.3% 36.4% 33.7% 28.1% 22.0% 54.8% 33.7%
% of Total 19.2% 7.7% 6.7% 33.7% 18.3% 9.6% 5.8% 33.7% 9.6% 5.8% 18.3% 33.7% 15.4% 14.4% 3.8% 33.7% 8.7% 8.7% 16.3% 33.7%
Count 38 20 11 69 37 25 7 69 22 17 30 69 32 30 7 69 23 32 14 69
% within 
Setting 55.1% 29.0% 15.9% 100.0% 53.6% 36.2% 10.1% 100.0% 31.9% 24.6% 43.5% 100.0% 46.4% 43.5% 10.1% 100.0% 33.3% 46.4% 20.3% 100.0%
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% within 
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Figure 26: Chi-Square analysis: Setting v. Barriers to ED Vaccination 
 
 
 
 
 
 
 Test Value df Asymp. Sig. (2-sided)  Test Value df
Asymp. Sig. 
(2-sided)
Pearson Chi-Square 0.139 2 0.933 Pearson Chi-Square 1.317 2 0.518
Likelihood Ratio 0.141 2 0.932 Likelihood Ratio 1.286 2 0.526
Linear-by-Linear 
Assoc
0.093 1 0.761 Linear-by-Linear 
Assoc
0.187 1 0.665
N of Valid Cases 104   N of Valid Cases 104   
Pearson Chi-Square 1.918 2 0.383 Pearson Chi-Square 1.248 2 0.536
Likelihood Ratio 1.868 2 0.393 Likelihood Ratio 1.262 2 0.532
Linear-by-Linear 
Assoc
1.883 1 0.17 Linear-by-Linear 
Assoc
0.61 1 0.435
N of Valid Cases 104   N of Valid Cases 104   
Pearson Chi-Square 0.285 2 0.867 Pearson Chi-Square 0.04 2 0.98
Likelihood Ratio 0.275 2 0.871 Likelihood Ratio 0.04 2 0.98
Linear-by-Linear 
Assoc
0.059 1 0.808 Linear-by-Linear 
Assoc
0.02 1 0.888
N of Valid Cases 104   N of Valid Cases 104   
Pearson Chi-Square 3.107 2 0.212 Pearson Chi-Square 9.184 2 0.01
Likelihood Ratio 3.045 2 0.218 Likelihood Ratio 8.988 2 0.011
Linear-by-Linear 
Assoc
0.81 1 0.368 Linear-by-Linear 
Assoc
4.894 1 0.027
N of Valid Cases 104   N of Valid Cases 104   
Pearson Chi-Square 0.195 2 0.907 Pearson Chi-Square 0.831 2 0.66
Likelihood Ratio 0.199 2 0.905 Likelihood Ratio 0.842 2 0.656
Linear-by-Linear 
Assoc
0.18 1 0.671 Linear-by-Linear 
Assoc
0.744 1 0.388
N of Valid Cases 104   N of Valid Cases 104   
Pearson Chi-Square 0.563 2 0.755 Pearson Chi-Square 1.504 2 0.471
Likelihood Ratio 0.567 2 0.753 Likelihood Ratio 1.554 2 0.46
Linear-by-Linear 
Assoc
0.016 1 0.901 Linear-by-Linear 
Assoc
0.146 1 0.702
N of Valid Cases 104   N of Valid Cases 104   
 Test Value df Asymp. Sig. (2-sided)
Exact Sig. 
(2-sided)
Exact Sig. 
(1-sided)
Pearson Chi-Square 0.762 1 0.383   
Continuity Correction 0.183 1 0.669   
Likelihood Ratio 0.722 1 0.395   
Fisher's Exact Test    0.402 0.323
Linear-by-Linear 
Assoc
0.755 1 0.385   
N of Valid Cases 104     
Pts Don’t 
Understand 
Need
Lack of Protocol
Pts Are Up-to-
Date
Setting v.
Believe Vaccine 
is Ineffective
Cost is 
Prohibitive
Pts Don't Want
Setting v.
Pts Unable to 
Provide Hx
Adverse Effects
Medicolegal 
Liability
Job of Primary 
Care
Setting v.
Physician Time 
Constraint
Nurse Time 
Constraint
Need Resources 
to Store
79 
 
Figure 27: Comparison of ED Annual Census and In-Patient Beds 
 
 
Figure 28: Cross tabulation: ED Census v. Vaccination Practices  
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Figure 29: Chi-Square analysis: ED Census v. Vaccination Practices 
 
Figure 30: Cross tabulation: ED Census v. Support for ED Vaccination 
  
 Test Value df
Asymp. Sig. (2-
sided)
Exact Sig. (2-
sided)
Exact Sig. (1-
sided)
Pearson Chi-Square 0.045 1 0.832   
Continuity Correction 0 1 0.988   
Likelihood Ratio 0.045 1 0.832   
Fisher's Exact Test
   0.847 0.494
Linear-by-Linear Assoc 0.044 1 0.833   
N of Valid Cases 104     
Pearson Chi-Square 0.315 1 0.575   
Continuity Correction 0.131 1 0.718   
Likelihood Ratio 0.315 1 0.575   
Fisher's Exact Test
   0.69 0.359
Linear-by-Linear Assoc 0.312 1 0.576   
N of Valid Cases 104     
Pearson Chi-Square 0.032 1 0.858   
Continuity Correction 0 1 1   
Likelihood Ratio 0.032 1 0.858   
Fisher's Exact Test
   1 0.535
Linear-by-Linear Assoc 0.032 1 0.859   
N of Valid Cases 104     
Pearson Chi-Square 0.002 1 0.961   
Continuity Correction 0 1 1   
Likelihood Ratio 0.002 1 0.961   
Fisher's Exact Test
   1 0.642
Linear-by-Linear Assoc 0.002 1 0.961   
N of Valid Cases 104     
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Figure 31: Chi-Square analysis: ED Census v. Support for ED Vaccination 
 
Figure 32: Cross tabulation: ED Census v. Barriers to ED Vaccination 
 
 
 Test Value df
Asymp. Sig. 
(2-sided)
Exact Sig. 
(2-sided)
Exact Sig. 
(1-sided)
Pearson Chi-Square 0.77 1 0.38   
Continuity Correction 0.45 1 0.501   
Likelihood Ratio 0.77 1 0.379   
Fisher's Exact Test
   0.418 0.25
Linear-by-Linear Assoc 0.76 1 0.382   
N of Valid Cases 104     
Disagree Neutral Agree Disagree Neutral Agree Disagree Neutral Agree Disagree Neutral Agree Disagree Neutral Agree
Count 11 10 32 53 11 7 35 53 5 5 43 53 7 7 39 53 6 6 41 53
% within ED 
Census 20.8% 18.9% 60.4% 100.0% 20.8% 13.2% 66.0% 100.0% 9.4% 9.4% 81.1% 100.0% 13.2% 13.2% 73.6% 100.0% 11.3% 11.3% 77.4% 100.0%
% within 
Barrier 47.8% 50.0% 52.5% 51.0% 73.3% 46.7% 47.3% 51.0% 83.3% 71.4% 47.3% 51.0% 63.6% 50.0% 49.4% 51.0% 42.9% 50.0% 52.6% 51.0%
% of Total 10.6% 9.6% 30.8% 51.0% 10.6% 6.7% 33.7% 51.0% 4.8% 4.8% 41.3% 51.0% 6.7% 6.7% 37.5% 51.0% 5.8% 5.8% 39.4% 51.0%
Count 12 10 29 51 4 8 39 51 1 2 48 51 4 7 40 51 8 6 37 51
% within ED 
Census 23.5% 19.6% 56.9% 100.0% 7.8% 15.7% 76.5% 100.0% 2.0% 3.9% 94.1% 100.0% 7.8% 13.7% 78.4% 100.0% 15.7% 11.8% 72.5% 100.0%
% within 
Barrier 52.2% 50.0% 47.5% 49.0% 26.7% 53.3% 52.7% 49.0% 16.7% 28.6% 52.7% 49.0% 36.4% 50.0% 50.6% 49.0% 57.1% 50.0% 47.4% 49.0%
% of Total 11.5% 9.6% 27.9% 49.0% 3.8% 7.7% 37.5% 49.0% 1.0% 1.9% 46.2% 49.0% 3.8% 6.7% 38.5% 49.0% 7.7% 5.8% 35.6% 49.0%
Count 23 20 61 104 15 15 74 104 6 7 91 104 11 14 79 104 14 12 78 104
% within ED 
Census 22.1% 19.2% 58.7% 100.0% 14.4% 14.4% 71.2% 100.0% 5.8% 6.7% 87.5% 100.0% 10.6% 13.5% 76.0% 100.0% 13.5% 11.5% 75.0% 100.0%
% within 
Barrier 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
% of Total 22.1% 19.2% 58.7% 100.0% 14.4% 14.4% 71.2% 100.0% 5.8% 6.7% 87.5% 100.0% 10.6% 13.5% 76.0% 100.0% 13.5% 11.5% 75.0% 100.0%
Disagree Neutral Agree Disagree Neutral Agree Disagree Neutral Agree Disagree Neutral Agree Disagree Neutral Agree
Count 30 13 10 53 30 13 10 53 17 13 23 53 23 23 7 53 15 21 17 53
% within ED 
Census 56.6% 24.5% 18.9% 100.0% 56.6% 24.5% 18.9% 100.0% 32.1% 24.5% 43.4% 100.0% 43.4% 43.4% 13.2% 100.0% 28.3% 39.6% 32.1% 100.0%
% within 
Barrier 51.7% 46.4% 55.6% 51.0% 53.6% 37.1% 76.9% 51.0% 53.1% 56.5% 46.9% 51.0% 47.9% 51.1% 63.6% 51.0% 46.9% 51.2% 54.8% 51.0%
% of Total 28.8% 12.5% 9.6% 51.0% 28.8% 12.5% 9.6% 51.0% 16.3% 12.5% 22.1% 51.0% 22.1% 22.1% 6.7% 51.0% 14.4% 20.2% 16.3% 51.0%
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% of Total 26.9% 14.4% 7.7% 49.0% 25.0% 21.2% 2.9% 49.0% 14.4% 9.6% 25.0% 49.0% 24.0% 21.2% 3.8% 49.0% 16.3% 19.2% 13.5% 49.0%
Count 58 28 18 104 56 35 13 104 32 23 49 104 48 45 11 104 32 41 31 104
% within ED 
Census 55.8% 26.9% 17.3% 100.0% 53.8% 33.7% 12.5% 100.0% 30.8% 22.1% 47.1% 100.0% 46.2% 43.3% 10.6% 100.0% 30.8% 39.4% 29.8% 100.0%
% within 
Barrier 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
% of Total 55.8% 26.9% 17.3% 100.0% 53.8% 33.7% 12.5% 100.0% 30.8% 22.1% 47.1% 100.0% 46.2% 43.3% 10.6% 100.0% 30.8% 39.4% 29.8% 100.0%
Disagree Neutral Agree Disagree Neutral Agree Disagree Neutral Agree
Count 48 5 0 53 11 7 35 53 34 12 7 53
% within ED 
Census 90.6% 9.4% 0.0% 100.0% 20.8% 13.2% 66.0% 100.0% 64.2% 22.6% 13.2% 100.0%
% within 
Barrier 49.0% 83.3% 0.0% 51.0% 44.0% 50.0% 53.8% 51.0% 47.2% 48.0% 100.0% 51.0%
% of Total 46.2% 4.8% 0.0% 51.0% 10.6% 6.7% 33.7% 51.0% 32.7% 11.5% 6.7% 51.0%
Count 50 1 0 51 14 7 30 51 38 13 0 51
% within ED 
Census 98.0% 2.0% 0.0% 100.0% 27.5% 13.7% 58.8% 100.0% 74.5% 25.5% 0.0% 100.0%
% within 
Barrier 51.0% 16.7% 0.0% 49.0% 56.0% 50.0% 46.2% 49.0% 52.8% 52.0% 0.0% 49.0%
% of Total 48.1% 1.0% 0.0% 49.0% 13.5% 6.7% 28.8% 49.0% 36.5% 12.5% 0.0% 49.0%
Count 98 6 0 104 25 14 65 104 72 25 7 104
% within ED 
Census 94.2% 5.8% 0.0% 100.0% 24.0% 13.5% 62.5% 100.0% 69.2% 24.0% 6.7% 100.0%
% within 
Barrier 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
% of Total 94.2% 5.8% 0.0% 100.0% 24.0% 13.5% 62.5% 100.0% 69.2% 24.0% 6.7% 100.0%
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Figure 33: Chi-Square analysis: ED Census v. Barriers to ED Vaccination 
 
 
 
 
 
 
 
 Test Value df Asymp. Sig. (2-sided)  Test Value df
Asymp. Sig. 
(2-sided)
Pearson Chi-Square 0.153 2 0.927 Pearson Chi-Square 6.333 2 0.042
Likelihood Ratio 0.153 2 0.927 Likelihood Ratio 6.565 2 0.038
Linear-by-Linear Assoc 0.151 1 0.698 Linear-by-Linear Assoc 0.283 1 0.595
N of Valid Cases 104   N of Valid Cases 104   
Pearson Chi-Square 3.512 2 0.173 Pearson Chi-Square 0.662 2 0.718
Likelihood Ratio 3.642 2 0.162 Likelihood Ratio 0.663 2 0.718
Linear-by-Linear Assoc 2.627 1 0.105 Linear-by-Linear Assoc 0.359 1 0.549
N of Valid Cases 104   N of Valid Cases 104   
Pearson Chi-Square 4.19 2 0.123 Pearson Chi-Square 0.886 2 0.642
Likelihood Ratio 4.476 2 0.107 Likelihood Ratio 0.896 2 0.639
Linear-by-Linear Assoc 4.07 1 0.044 Linear-by-Linear Assoc 0.705 1 0.401
N of Valid Cases 104   N of Valid Cases 104   
Pearson Chi-Square 0.793 2 0.673 Pearson Chi-Square 0.401 2 0.818
Likelihood Ratio 0.803 2 0.669 Likelihood Ratio 0.402 2 0.818
Linear-by-Linear Assoc 0.613 1 0.434 Linear-by-Linear Assoc 0.396 1 0.529
N of Valid Cases 104   N of Valid Cases 104   
Pearson Chi-Square 0.453 2 0.797 Pearson Chi-Square 0.706 2 0.702
Likelihood Ratio 0.453 2 0.797 Likelihood Ratio 0.707 2 0.702
Linear-by-Linear Assoc 0.428 1 0.513 Linear-by-Linear Assoc 0.694 1 0.405
N of Valid Cases 104   N of Valid Cases 104   
Pearson Chi-Square 0.396 2 0.82 Pearson Chi-Square 7.226 2 0.027
Likelihood Ratio 0.396 2 0.82 Likelihood Ratio 9.928 2 0.007
Linear-by-Linear Assoc 0.01 1 0.922 Linear-by-Linear Assoc 3.874 1 0.049
N of Valid Cases 104   N of Valid Cases 104   
 Test Value df Asymp. Sig. (2-sided)
Exact Sig. 
(2-sided)
Exact Sig. 
(1-sided)
Pearson Chi-Square 2.67 1 0.102   
Continuity Correction 1.472 1 0.225   
Likelihood Ratio 2.913 1 0.088   
Fisher's Exact Test    0.205 0.112
Linear-by-Linear Assoc 2.644 1 0.104   
N of Valid Cases 104     
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Figure 34: Cross tabulation: Academic v. Vaccination Practices 
 
Figure 35: Chi-Square analysis: Academic v. Vaccination Practices 
 
Total Total Total Total
No Yes No Yes No Yes No Yes
Count 26 28 54 32 22 54 49 5 54 51 3 54
% within 
Academic 
Status
48.1% 51.9% 100.0% 59.3% 40.7% 100.0% 90.7% 9.3% 100.0% 94.4% 5.6% 100.0%
% within 
Screening 
or Admin
54.2% 50.0% 51.9% 51.6% 52.4% 51.9% 56.3% 29.4% 51.9% 52.0% 50.0% 51.9%
% of Total 25.0% 26.9% 51.9% 30.8% 21.2% 51.9% 47.1% 4.8% 51.9% 49.0% 2.9% 51.9%
Count 22 28 50 30 20 50 38 12 50 47 3 50
% within 
Academic 
Status
44.0% 56.0% 100.0% 60.0% 40.0% 100.0% 76.0% 24.0% 100.0% 94.0% 6.0% 100.0%
% within 
Screening 
or Admin
45.8% 50.0% 48.1% 48.4% 47.6% 48.1% 43.7% 70.6% 48.1% 48.0% 50.0% 48.1%
% of Total 21.2% 26.9% 48.1% 28.8% 19.2% 48.1% 36.5% 11.5% 48.1% 45.2% 2.9% 48.1%
Count 48 56 104 62 42 104 87 17 104 98 6 104
% within 
Academic 
Status
46.2% 53.8% 100.0% 59.6% 40.4% 100.0% 83.7% 16.3% 100.0% 94.2% 5.8% 100.0%
% within 
Screening 
or Admin
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
% of Total 46.2% 53.8% 100.0% 59.6% 40.4% 100.0% 83.7% 16.3% 100.0% 94.2% 5.8% 100.0%
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Asymp. Sig. 
(2-sided)
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(2-sided)
Exact Sig. 
(1-sided)
Pearson Chi-Square 0.18 1 0.672   
Continuity Correction 0.052 1 0.82   
Likelihood Ratio 0.18 1 0.672   
Fisher's Exact Test
   0.698 0.41
Linear-by-Linear Assoc 0.178 1 0.673   
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Pearson Chi-Square 0.006 1 0.939   
Continuity Correction 0 1 1   
Likelihood Ratio 0.006 1 0.939   
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   1 0.549
Linear-by-Linear Assoc 0.006 1 0.939   
N of Valid Cases 104     
Pearson Chi-Square 4.125 1 0.042   
Continuity Correction 3.118 1 0.077   
Likelihood Ratio 4.211 1 0.04   
Fisher's Exact Test
   0.062 0.038
Linear-by-Linear Assoc 4.086 1 0.043   
N of Valid Cases 104     
Pearson Chi-Square 0.009 1 0.923   
Continuity Correction 0 1 1   
Likelihood Ratio 0.009 1 0.923   
Fisher's Exact Test
   1 0.623
Linear-by-Linear Assoc 0.009 1 0.923   
N of Valid Cases 104     
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Figure 36: Cross tabulation: Academic v. Support for ED Vaccination 
 
 
Figure 37: Chi-Square analysis: Academic v. Support for ED Vaccination 
 
 
 
 
 
No Yes
Count 37 17 54
% within 
Academic 
Status
68.5% 31.5% 100.0%
% within 
Support 55.2% 45.9% 51.9%
% of Total 35.6% 16.3% 51.9%
Count 30 20 50
% within 
Academic 
Status
60.0% 40.0% 100.0%
% within 
Support 44.8% 54.1% 48.1%
% of Total 28.8% 19.2% 48.1%
Count 67 37 104
% within 
Academic 
Status
64.4% 35.6% 100.0%
% within 
Support 100.0% 100.0% 100.0%
% of Total 64.4% 35.6% 100.0%
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(2-sided)
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Exact Sig. 
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Pearson Chi-Square 0.82 1 0.365   
Continuity Correction 0.49 1 0.483   
Likelihood Ratio 0.82 1 0.365   
Fisher's Exact Test
   0.416 0.241
Linear-by-Linear Assoc 0.81 1 0.367   
N of Valid Cases 104     
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Figure 38: Cross tabulation: Academic v. Barriers to ED Vaccination 
 
 
 
 
Disagree Neutral Agree Disagree Neutral Agree Disagree Neutral Agree Disagree Neutral Agree Disagree Neutral Agree
Count 8 9 37 54 9 7 38 54 3 5 46 54 7 5 42 54 4 6 44 54
% within 
Academic 
Status
14.8% 16.7% 68.5% 100.0% 16.7% 13.0% 70.4% 100.0% 5.6% 9.3% 85.2% 100.0% 13.0% 9.3% 77.8% 100.0% 7.4% 11.1% 81.5% 100.0%
% within 
Barrier 34.8% 45.0% 60.7% 51.9% 60.0% 46.7% 51.4% 51.9% 50.0% 71.4% 50.5% 51.9% 63.6% 35.7% 53.2% 51.9% 28.6% 50.0% 56.4% 51.9%
% of Total 7.7% 8.7% 35.6% 51.9% 8.7% 6.7% 36.5% 51.9% 2.9% 4.8% 44.2% 51.9% 6.7% 4.8% 40.4% 51.9% 3.8% 5.8% 42.3% 51.9%
Count 15 11 24 50 6 8 36 50 3 2 45 50 4 9 37 50 10 6 34 50
% within 
Academic 
Status
30.0% 22.0% 48.0% 100.0% 12.0% 16.0% 72.0% 100.0% 6.0% 4.0% 90.0% 100.0% 8.0% 18.0% 74.0% 100.0% 20.0% 12.0% 68.0% 100.0%
% within 
Barrier 65.2% 55.0% 39.3% 48.1% 40.0% 53.3% 48.6% 48.1% 50.0% 28.6% 49.5% 48.1% 36.4% 64.3% 46.8% 48.1% 71.4% 50.0% 43.6% 48.1%
% of Total 14.4% 10.6% 23.1% 48.1% 5.8% 7.7% 34.6% 48.1% 2.9% 1.9% 43.3% 48.1% 3.8% 8.7% 35.6% 48.1% 9.6% 5.8% 32.7% 48.1%
Count 23 20 61 104 15 15 74 104 6 7 91 104 11 14 79 104 14 12 78 104
% within 
Academic 
Status
22.1% 19.2% 58.7% 100.0% 14.4% 14.4% 71.2% 100.0% 5.8% 6.7% 87.5% 100.0% 10.6% 13.5% 76.0% 100.0% 13.5% 11.5% 75.0% 100.0%
% within 
Barrier 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
% of Total 22.1% 19.2% 58.7% 100.0% 14.4% 14.4% 71.2% 100.0% 5.8% 6.7% 87.5% 100.0% 10.6% 13.5% 76.0% 100.0% 13.5% 11.5% 75.0% 100.0%
Disagree Neutral Agree Disagree Neutral Agree Disagree Neutral Agree Disagree Neutral Agree Disagree Neutral Agree
Count 27 15 12 54 28 17 9 54 17 13 24 54 26 22 6 54 14 21 19 54
% within 
Academic 
Status
50.0% 27.8% 22.2% 100.0% 51.9% 31.5% 16.7% 100.0% 31.5% 24.1% 44.4% 100.0% 48.1% 40.7% 11.1% 100.0% 25.9% 38.9% 35.2% 100.0%
% within 
Barrier 46.6% 53.6% 66.7% 51.9% 50.0% 48.6% 69.2% 51.9% 53.1% 56.5% 49.0% 51.9% 54.2% 48.9% 54.5% 51.9% 43.8% 51.2% 61.3% 51.9%
% of Total 26.0% 14.4% 11.5% 51.9% 26.9% 16.3% 8.7% 51.9% 16.3% 12.5% 23.1% 51.9% 25.0% 21.2% 5.8% 51.9% 13.5% 20.2% 18.3% 51.9%
Count 31 13 6 50 28 18 4 50 15 10 25 50 22 23 5 50 18 20 12 50
% within 
Academic 
Status
62.0% 26.0% 12.0% 100.0% 56.0% 36.0% 8.0% 100.0% 30.0% 20.0% 50.0% 100.0% 44.0% 46.0% 10.0% 100.0% 36.0% 40.0% 24.0% 100.0%
% within 
Barrier 53.4% 46.4% 33.3% 48.1% 50.0% 51.4% 30.8% 48.1% 46.9% 43.5% 51.0% 48.1% 45.8% 51.1% 45.5% 48.1% 56.3% 48.8% 38.7% 48.1%
% of Total 29.8% 12.5% 5.8% 48.1% 26.9% 17.3% 3.8% 48.1% 14.4% 9.6% 24.0% 48.1% 21.2% 22.1% 4.8% 48.1% 17.3% 19.2% 11.5% 48.1%
Count 58 28 18 104 56 35 13 104 32 23 49 104 48 45 11 104 32 41 31 104
% within 
Academic 
Status
55.8% 26.9% 17.3% 100.0% 53.8% 33.7% 12.5% 100.0% 30.8% 22.1% 47.1% 100.0% 46.2% 43.3% 10.6% 100.0% 30.8% 39.4% 29.8% 100.0%
% within 
Barrier 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
% of Total 55.8% 26.9% 17.3% 100.0% 53.8% 33.7% 12.5% 100.0% 30.8% 22.1% 47.1% 100.0% 46.2% 43.3% 10.6% 100.0% 30.8% 39.4% 29.8% 100.0%
Disagree Neutral Agree Disagree Neutral Agree Disagree Neutral Agree
Count 51 3 0 54 12 5 37 54 35 13 6 54
% within 
Academic 
Status
94.4% 5.6% 0.0% 100.0% 22.2% 9.3% 68.5% 100.0% 64.8% 24.1% 11.1% 100.0%
% within 
Barrier 52.0% 50.0% 0.0% 51.9% 48.0% 35.7% 56.9% 51.9% 48.6% 52.0% 85.7% 51.9%
% of Total 49.0% 2.9% 0.0% 51.9% 11.5% 4.8% 35.6% 51.9% 33.7% 12.5% 5.8% 51.9%
Count 47 3 0 50 13 9 28 50 37 12 1 50
% within 
Academic 
Status
94.0% 6.0% 0.0% 100.0% 26.0% 18.0% 56.0% 100.0% 74.0% 24.0% 2.0% 100.0%
% within 
Barrier 48.0% 50.0% 0.0% 48.1% 52.0% 64.3% 43.1% 48.1% 51.4% 48.0% 14.3% 48.1%
% of Total 45.2% 2.9% 0.0% 48.1% 12.5% 8.7% 26.9% 48.1% 35.6% 11.5% 1.0% 48.1%
Count 98 6 0 104 25 14 65 104 72 25 7 104
% within 
Academic 
Status
94.2% 5.8% 0.0% 100.0% 24.0% 13.5% 62.5% 100.0% 69.2% 24.0% 6.7% 100.0%
% within 
Barrier 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
% of Total 94.2% 5.8% 0.0% 100.0% 24.0% 13.5% 62.5% 100.0% 69.2% 24.0% 6.7% 100.0%
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Figure 39: Chi-Square analysis: Academic v. Barriers to ED Vaccination 
 
 
 
 
 
 
 Test Value df Asymp. Sig. (2-sided)  Test Value df
Asymp. Sig. 
(2-sided)
Pearson Chi-Square 4.954 2 0.084 Pearson Chi-Square 1.8 2 0.406
Likelihood Ratio 5.003 2 0.082 Likelihood Ratio 1.848 2 0.397
Linear-by-Linear Assoc 4.862 1 0.027 Linear-by-Linear Assoc 0.857 1 0.354
N of Valid Cases 104   N of Valid Cases 104   
Pearson Chi-Square 0.568 2 0.753 Pearson Chi-Square 0.383 2 0.826
Likelihood Ratio 0.571 2 0.752 Likelihood Ratio 0.384 2 0.825
Linear-by-Linear Assoc 0.191 1 0.662 Linear-by-Linear Assoc 0.169 1 0.681
N of Valid Cases 104   N of Valid Cases 104   
Pearson Chi-Square 1.145 2 0.564 Pearson Chi-Square 0.293 2 0.864
Likelihood Ratio 1.185 2 0.553 Likelihood Ratio 0.293 2 0.864
Linear-by-Linear Assoc 0.186 1 0.667 Linear-by-Linear Assoc 0.054 1 0.817
N of Valid Cases 104   N of Valid Cases 104   
Pearson Chi-Square 2.127 2 0.345 Pearson Chi-Square 1.954 2 0.376
Likelihood Ratio 2.15 2 0.341 Likelihood Ratio 1.966 2 0.374
Linear-by-Linear Assoc 0.008 1 0.928 Linear-by-Linear Assoc 1.919 1 0.166
N of Valid Cases 104   N of Valid Cases 104   
Pearson Chi-Square 3.705 2 0.157 Pearson Chi-Square 2.279 2 0.32
Likelihood Ratio 3.788 2 0.15 Likelihood Ratio 2.295 2 0.317
Linear-by-Linear Assoc 3.455 1 0.063 Linear-by-Linear Assoc 0.952 1 0.329
N of Valid Cases 104   N of Valid Cases 104   
Pearson Chi-Square 2.268 2 0.322 Pearson Chi-Square 3.518 2 0.172
Likelihood Ratio 2.304 2 0.316 Likelihood Ratio 3.904 2 0.142
Linear-by-Linear Assoc 2.179 1 0.14 Linear-by-Linear Assoc 2.333 1 0.127
N of Valid Cases 104   N of Valid Cases 104   
 Test Value df Asymp. Sig. (2-sided)
Exact Sig. 
(2-sided)
Exact Sig. 
(1-sided)
Pearson Chi-Square 0.009 1 0.923   
Continuity Correction 0 1 1   
Likelihood Ratio 0.009 1 0.923   
Fisher's Exact Test    1 0.623
Linear-by-Linear Assoc 0.009 1 0.923   
N of Valid Cases 104     
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Figure 40: Cross tabulation: Admin of Influenza v. Support for ED Vacc 
 
 
Figure 41: Chi-Square analysis: Admin of Influenza v. Support for ED Vacc 
 
 
 
 
No Yes
Count 62 25 87
% within 
Influenza 71.3% 28.7% 100.0%
% within 
Support 92.5% 67.6% 83.7%
% of Total 59.6% 24.0% 83.7%
Count 5 12 17
% within 
Influenza 29.4% 70.6% 100.0%
% within 
Support 7.5% 32.4% 16.3%
% of Total 4.8% 11.5% 16.3%
Count 67 37 104
% within 
Influenza 64.4% 35.6% 100.0%
% within 
Support 100.0% 100.0% 100.0%
% of Total 64.4% 35.6% 100.0%
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 Test Value df
Asymp. Sig. 
(2-sided)
Exact Sig. 
(2-sided)
Exact Sig. 
(1-sided)
Pearson Chi-Square 10.9 1 0.001   
Continuity Correction 9.12 1 0.003   
Likelihood Ratio 10.4 1 0.001   
Fisher's Exact Test
   0.002 0.002
Linear-by-Linear Assoc 10.8 1 0.001   
N of Valid Cases 104     
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Figure 42: Cross tabulation: Admin of Influenza v. Barriers to ED Vacc 
 
 
 
 
 
Disagree Neutral Agree Disagree Neutral Agree Disagree Neutral Agree Disagree Neutral Agree Disagree Neutral Agree
Count 14 18 55 87 10 14 63 87 2 7 78 87 7 12 68 87 11 9 67 87
% within 
Influenza 16.1% 20.7% 63.2% 100.0% 11.5% 16.1% 72.4% 100.0% 2.3% 8.0% 89.7% 100.0% 8.0% 13.8% 78.2% 100.0% 12.6% 10.3% 77.0% 100.0%
% within 
Barrier 60.9% 90.0% 90.2% 83.7% 66.7% 93.3% 85.1% 83.7% 33.3% 100.0% 85.7% 83.7% 63.6% 85.7% 86.1% 83.7% 78.6% 75.0% 85.9% 83.7%
% of Total 13.5% 17.3% 52.9% 83.7% 9.6% 13.5% 60.6% 83.7% 1.9% 6.7% 75.0% 83.7% 6.7% 11.5% 65.4% 83.7% 10.6% 8.7% 64.4% 83.7%
Count 9 2 6 17 5 1 11 17 4 0 13 17 4 2 11 17 3 3 11 17
% within 
Influenza 52.9% 11.8% 35.3% 100.0% 29.4% 5.9% 64.7% 100.0% 23.5% 0.0% 76.5% 100.0% 23.5% 11.8% 64.7% 100.0% 17.6% 17.6% 64.7% 100.0%
% within 
Barrier 39.1% 10.0% 9.8% 16.3% 33.3% 6.7% 14.9% 16.3% 66.7% 0.0% 14.3% 16.3% 36.4% 14.3% 13.9% 16.3% 21.4% 25.0% 14.1% 16.3%
% of Total 8.7% 1.9% 5.8% 16.3% 4.8% 1.0% 10.6% 16.3% 3.8% 0.0% 12.5% 16.3% 3.8% 1.9% 10.6% 16.3% 2.9% 2.9% 10.6% 16.3%
Count 23 20 61 104 15 15 74 104 6 7 91 104 11 14 79 104 14 12 78 104
% within 
Influenza 22.1% 19.2% 58.7% 100.0% 14.4% 14.4% 71.2% 100.0% 5.8% 6.7% 87.5% 100.0% 10.6% 13.5% 76.0% 100.0% 13.5% 11.5% 75.0% 100.0%
% within 
Barrier 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
% of Total 22.1% 19.2% 58.7% 100.0% 14.4% 14.4% 71.2% 100.0% 5.8% 6.7% 87.5% 100.0% 10.6% 13.5% 76.0% 100.0% 13.5% 11.5% 75.0% 100.0%
Disagree Neutral Agree Disagree Neutral Agree Disagree Neutral Agree Disagree Neutral Agree Disagree Neutral Agree
Count 49 22 16 87 50 24 13 87 24 19 44 87 37 40 10 87 23 38 26 87
% within 
Influenza 56.3% 25.3% 18.4% 100.0% 57.5% 27.6% 14.9% 100.0% 27.6% 21.8% 50.6% 100.0% 42.5% 46.0% 11.5% 100.0% 26.4% 43.7% 29.9% 100.0%
% within 
Barrier 84.5% 78.6% 88.9% 83.7% 89.3% 68.6% 100.0% 83.7% 75.0% 82.6% 89.8% 83.7% 77.1% 88.9% 90.9% 83.7% 71.9% 92.7% 83.9% 83.7%
% of Total 47.1% 21.2% 15.4% 83.7% 48.1% 23.1% 12.5% 83.7% 23.1% 18.3% 42.3% 83.7% 35.6% 38.5% 9.6% 83.7% 22.1% 36.5% 25.0% 83.7%
Count 9 6 2 17 6 11 0 17 8 4 5 17 11 5 1 17 9 3 5 17
% within 
Influenza 52.9% 35.3% 11.8% 100.0% 35.3% 64.7% 0.0% 100.0% 47.1% 23.5% 29.4% 100.0% 64.7% 29.4% 5.9% 100.0% 52.9% 17.6% 29.4% 100.0%
% within 
Barrier 15.5% 21.4% 11.1% 16.3% 10.7% 31.4% 0.0% 16.3% 25.0% 17.4% 10.2% 16.3% 22.9% 11.1% 9.1% 16.3% 28.1% 7.3% 16.1% 16.3%
% of Total 8.7% 5.8% 1.9% 16.3% 5.8% 10.6% 0.0% 16.3% 7.7% 3.8% 4.8% 16.3% 10.6% 4.8% 1.0% 16.3% 8.7% 2.9% 4.8% 16.3%
Count 58 28 18 104 56 35 13 104 32 23 49 104 48 45 11 104 32 41 31 104
% within 
Influenza 55.8% 26.9% 17.3% 100.0% 53.8% 33.7% 12.5% 100.0% 30.8% 22.1% 47.1% 100.0% 46.2% 43.3% 10.6% 100.0% 30.8% 39.4% 29.8% 100.0%
% within 
Barrier 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
% of Total 55.8% 26.9% 17.3% 100.0% 53.8% 33.7% 12.5% 100.0% 30.8% 22.1% 47.1% 100.0% 46.2% 43.3% 10.6% 100.0% 30.8% 39.4% 29.8% 100.0%
Disagree Neutral Agree Disagree Neutral Agree Disagree Neutral Agree
Count 81 6 0 87 19 12 56 87 57 23 7 87
% within 
Influenza 93.1% 6.9% 0.0% 100.0% 21.8% 13.8% 64.4% 100.0% 65.5% 26.4% 8.0% 100.0%
% within 
Barrier 82.7% 100.0% 0.0% 83.7% 76.0% 85.7% 86.2% 83.7% 79.2% 92.0% 100.0% 83.7%
% of Total 77.9% 5.8% 0.0% 83.7% 18.3% 11.5% 53.8% 83.7% 54.8% 22.1% 6.7% 83.7%
Count 17 0 0 17 6 2 9 17 15 2 0 17
% within 
Influenza 100.0% 0.0% 0.0% 100.0% 35.3% 11.8% 52.9% 100.0% 88.2% 11.8% 0.0% 100.0%
% within 
Barrier 17.3% 0.0% 0.0% 16.3% 24.0% 14.3% 13.8% 16.3% 20.8% 8.0% 0.0% 16.3%
% of Total 16.3% 0.0% 0.0% 16.3% 5.8% 1.9% 8.7% 16.3% 14.4% 1.9% 0.0% 16.3%
Count 98 6 0 104 25 14 65 104 72 25 7 104
% within 
Influenza 94.2% 5.8% 0.0% 100.0% 24.0% 13.5% 62.5% 100.0% 69.2% 24.0% 6.7% 100.0%
% within 
Barrier 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
% of Total 94.2% 5.8% 0.0% 100.0% 24.0% 13.5% 62.5% 100.0% 69.2% 24.0% 6.7% 100.0%
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Figure 43: Chi-Square analysis: Admin of Influenza v. Barriers to ED Vacc 
 
 
 
 
 
 
 Test Value df Asymp. Sig. (2-sided)  Test Value df
Asymp. Sig. 
(2-sided)
Pearson Chi-Square 11.21 2 0.004 Pearson Chi-Square 9.662 2 0.008
Likelihood Ratio 9.625 2 0.008 Likelihood Ratio 10.93 2 0.004
Linear-by-Linear Assoc 8.765 1 0.003 Linear-by-Linear Assoc 0.15 1 0.699
N of Valid Cases 104   N of Valid Cases 104   
Pearson Chi-Square 4.312 2 0.116 Pearson Chi-Square 3.123 2 0.21
Likelihood Ratio 3.98 2 0.137 Likelihood Ratio 3.098 2 0.213
Linear-by-Linear Assoc 1.732 1 0.188 Linear-by-Linear Assoc 3.092 1 0.079
N of Valid Cases 104   N of Valid Cases 104   
Pearson Chi-Square 12.76 2 0.002 Pearson Chi-Square 2.841 2 0.242
Likelihood Ratio 10.36 2 0.006 Likelihood Ratio 2.865 2 0.239
Linear-by-Linear Assoc 6.302 1 0.012 Linear-by-Linear Assoc 2.468 1 0.116
N of Valid Cases 104   N of Valid Cases 104   
Pearson Chi-Square 3.606 2 0.165 Pearson Chi-Square 5.692 2 0.058
Likelihood Ratio 2.966 2 0.227 Likelihood Ratio 5.755 2 0.056
Linear-by-Linear Assoc 2.694 1 0.101 Linear-by-Linear Assoc 1.692 1 0.193
N of Valid Cases 104   N of Valid Cases 104   
Pearson Chi-Square 1.209 2 0.546 Pearson Chi-Square 1.412 2 0.494
Likelihood Ratio 1.128 2 0.569 Likelihood Ratio 1.318 2 0.517
Linear-by-Linear Assoc 0.834 1 0.361 Linear-by-Linear Assoc 1.215 1 0.27
N of Valid Cases 104   N of Valid Cases 104   
Pearson Chi-Square 0.919 2 0.632 Pearson Chi-Square 3.702 2 0.157
Likelihood Ratio 0.919 2 0.632 Likelihood Ratio 5.007 2 0.082
Linear-by-Linear Assoc 0.025 1 0.873 Linear-by-Linear Assoc 3.613 1 0.057
N of Valid Cases 104   N of Valid Cases 104   
 Test Value df Asymp. Sig. (2-sided)
Exact Sig. 
(2-sided)
Exact Sig. 
(1-sided)
Pearson Chi-Square 1.244 1 0.265   
Continuity Correction 0.299 1 0.585   
Likelihood Ratio 2.212 1 0.137   
Fisher's Exact Test    0.586 0.333
Linear-by-Linear Assoc 1.232 1 0.267   
N of Valid Cases 104     
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Figure 44: Cross tabulation: Admin of Pneumo v. Support for ED Vacc 
 
 
Figure 45: Chi-Square analysis: Admin of Pneumo v. Support for ED Vacc 
 
 
 
 
No Yes
Count 65 33 98
% within 
Pneumo 66.3% 33.7% 100.0%
% within 
Support 97.0% 89.2% 94.2%
% of Total 62.5% 31.7% 94.2%
Count 2 4 6
% within 
Pneumo 33.3% 66.7% 100.0%
% within 
Support 3.0% 10.8% 5.8%
% of Total 1.9% 3.8% 5.8%
Count 67 37 104
% within 
Pneumo 64.4% 35.6% 100.0%
% within 
Support 100.0% 100.0% 100.0%
% of Total 64.4% 35.6% 100.0%
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Exact Sig. 
(1-sided)
Pearson Chi-Square 2.685 1 0.101   
Continuity Correction 1.439 1 0.23   
Likelihood Ratio 2.545 1 0.111   
Fisher's Exact Test
   0.183 0.117
Linear-by-Linear Assoc 2.659 1 0.103   
N of Valid Cases 104     
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Figure 46: Cross tabulation: Admin of Pneumo v. Barriers to ED Vacc 
 
 
 
 
 
Disagree Neutral Agree Disagree Neutral Agree Disagree Neutral Agree Disagree Neutral Agree Disagree Neutral Agree
Count 20 19 59 98 13 14 71 98 4 7 87 98 8 12 78 98 13 12 73 98
% within 
Pneumo 20.4% 19.4% 60.2% 100.0% 13.3% 14.3% 72.4% 100.0% 4.1% 7.1% 88.8% 100.0% 8.2% 12.2% 79.6% 100.0% 13.3% 12.2% 74.5% 100.0%
% within 
Barrier 87.0% 95.0% 96.7% 94.2% 86.7% 93.3% 95.9% 94.2% 66.7% 100.0% 95.6% 94.2% 72.7% 85.7% 98.7% 94.2% 92.9% 100.0% 93.6% 94.2%
% of Total 19.2% 18.3% 56.7% 94.2% 12.5% 13.5% 68.3% 94.2% 3.8% 6.7% 83.7% 94.2% 7.7% 11.5% 75.0% 94.2% 12.5% 11.5% 70.2% 94.2%
Count 3 1 2 6 2 1 3 6 2 0 4 6 3 2 1 6 1 0 5 6
% within 
Pneumo 50.0% 16.7% 33.3% 100.0% 33.3% 16.7% 50.0% 100.0% 33.3% 0.0% 66.7% 100.0% 50.0% 33.3% 16.7% 100.0% 16.7% 0.0% 83.3% 100.0%
% within 
Barrier 13.0% 5.0% 3.3% 5.8% 13.3% 6.7% 4.1% 5.8% 33.3% 0.0% 4.4% 5.8% 27.3% 14.3% 1.3% 5.8% 7.1% 0.0% 6.4% 5.8%
% of Total 2.9% 1.0% 1.9% 5.8% 1.9% 1.0% 2.9% 5.8% 1.9% 0.0% 3.8% 5.8% 2.9% 1.9% 1.0% 5.8% 1.0% 0.0% 4.8% 5.8%
Count 23 20 61 104 15 15 74 104 6 7 91 104 11 14 79 104 14 12 78 104
% within 
Pneumo 22.1% 19.2% 58.7% 100.0% 14.4% 14.4% 71.2% 100.0% 5.8% 6.7% 87.5% 100.0% 10.6% 13.5% 76.0% 100.0% 13.5% 11.5% 75.0% 100.0%
% within 
Barrier 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
% of Total 22.1% 19.2% 58.7% 100.0% 14.4% 14.4% 71.2% 100.0% 5.8% 6.7% 87.5% 100.0% 10.6% 13.5% 76.0% 100.0% 13.5% 11.5% 75.0% 100.0%
Disagree Neutral Agree Disagree Neutral Agree Disagree Neutral Agree Disagree Neutral Agree Disagree Neutral Agree
Count 55 25 18 98 54 31 13 98 28 21 49 98 45 44 9 98 29 40 29 98
% within 
Pneumo 56.1% 25.5% 18.4% 100.0% 55.1% 31.6% 13.3% 100.0% 28.6% 21.4% 50.0% 100.0% 45.9% 44.9% 9.2% 100.0% 29.6% 40.8% 29.6% 100.0%
% within 
Barrier 94.8% 89.3% 100.0% 94.2% 96.4% 88.6% 100.0% 94.2% 87.5% 91.3% 100.0% 94.2% 93.8% 97.8% 81.8% 94.2% 90.6% 97.6% 93.5% 94.2%
% of Total 52.9% 24.0% 17.3% 94.2% 51.9% 29.8% 12.5% 94.2% 26.9% 20.2% 47.1% 94.2% 43.3% 42.3% 8.7% 94.2% 27.9% 38.5% 27.9% 94.2%
Count 3 3 0 6 2 4 0 6 4 2 0 6 3 1 2 6 3 1 2 6
% within 
Pneumo 50.0% 50.0% 0.0% 100.0% 33.3% 66.7% 0.0% 100.0% 66.7% 33.3% 0.0% 100.0% 50.0% 16.7% 33.3% 100.0% 50.0% 16.7% 33.3% 100.0%
% within 
Barrier 5.2% 10.7% 0.0% 5.8% 3.6% 11.4% 0.0% 5.8% 12.5% 8.7% 0.0% 5.8% 6.3% 2.2% 18.2% 5.8% 9.4% 2.4% 6.5% 5.8%
% of Total 2.9% 2.9% 0.0% 5.8% 1.9% 3.8% 0.0% 5.8% 3.8% 1.9% 0.0% 5.8% 2.9% 1.0% 1.9% 5.8% 2.9% 1.0% 1.9% 5.8%
Count 58 28 18 104 56 35 13 104 32 23 49 104 48 45 11 104 32 41 31 104
% within 
Pneumo 55.8% 26.9% 17.3% 100.0% 53.8% 33.7% 12.5% 100.0% 30.8% 22.1% 47.1% 100.0% 46.2% 43.3% 10.6% 100.0% 30.8% 39.4% 29.8% 100.0%
% within 
Barrier 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
% of Total 55.8% 26.9% 17.3% 100.0% 53.8% 33.7% 12.5% 100.0% 30.8% 22.1% 47.1% 100.0% 46.2% 43.3% 10.6% 100.0% 30.8% 39.4% 29.8% 100.0%
Disagree Neutral Agree Disagree Neutral Agree Disagree Neutral Agree
Count 92 6 0 98 22 14 62 98 67 24 7 98
% within 
Pneumo 93.9% 6.1% 0.0% 100.0% 22.4% 14.3% 63.3% 100.0% 68.4% 24.5% 7.1% 100.0%
% within 
Barrier 93.9% 100.0% 0.0% 94.2% 88.0% 100.0% 95.4% 94.2% 93.1% 96.0% 100.0% 94.2%
% of Total 88.5% 5.8% 0.0% 94.2% 21.2% 13.5% 59.6% 94.2% 64.4% 23.1% 6.7% 94.2%
Count 6 0 0 6 3 0 3 6 5 1 0 6
% within 
Pneumo 100.0% 0.0% 0.0% 100.0% 50.0% 0.0% 50.0% 100.0% 83.3% 16.7% 0.0% 100.0%
% within 
Barrier 6.1% 0.0% 0.0% 5.8% 12.0% 0.0% 4.6% 5.8% 6.9% 4.0% 0.0% 5.8%
% of Total 5.8% 0.0% 0.0% 5.8% 2.9% 0.0% 2.9% 5.8% 4.8% 1.0% 0.0% 5.8%
Count 98 6 0 104 25 14 65 104 72 25 7 104
% within 
Pneumo 94.2% 5.8% 0.0% 100.0% 24.0% 13.5% 62.5% 100.0% 69.2% 24.0% 6.7% 100.0%
% within 
Barrier 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
% of Total 94.2% 5.8% 0.0% 100.0% 24.0% 13.5% 62.5% 100.0% 69.2% 24.0% 6.7% 100.0%
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Figure 47: Chi-Square analysis: Admin of Pneumo v. Barriers to ED Vacc 
 
 
 
 
 
 
 Test Value df Asymp. Sig. (2-sided)  Test Value df
Asymp. Sig. 
(2-sided)
Pearson Chi-Square 2.956 2 0.228 Pearson Chi-Square 3.355 2 0.187
Likelihood Ratio 2.522 2 0.283 Likelihood Ratio 3.745 2 0.154
Linear-by-Linear Assoc 2.648 1 0.104 Linear-by-Linear Assoc 0.082 1 0.774
N of Valid Cases 104   N of Valid Cases 104   
Pearson Chi-Square 2.001 2 0.368 Pearson Chi-Square 6.029 2 0.049
Likelihood Ratio 1.641 2 0.44 Likelihood Ratio 8.175 2 0.017
Linear-by-Linear Assoc 1.896 1 0.169 Linear-by-Linear Assoc 5.778 1 0.016
N of Valid Cases 104   N of Valid Cases 104   
Pearson Chi-Square 9.13 2 0.01 Pearson Chi-Square 4.179 2 0.124
Likelihood Ratio 5.422 2 0.066 Likelihood Ratio 3.413 2 0.182
Linear-by-Linear Assoc 5.58 1 0.018 Linear-by-Linear Assoc 0.512 1 0.474
N of Valid Cases 104   N of Valid Cases 104   
Pearson Chi-Square 9.13 2 0.01 Pearson Chi-Square 1.628 2 0.443
Likelihood Ratio 5.422 2 0.066 Likelihood Ratio 1.732 2 0.421
Linear-by-Linear Assoc 5.58 1 0.018 Linear-by-Linear Assoc 0.257 1 0.612
N of Valid Cases 104   N of Valid Cases 104   
Pearson Chi-Square 0.842 2 0.656 Pearson Chi-Square 2.802 2 0.246
Likelihood Ratio 1.529 2 0.466 Likelihood Ratio 3.218 2 0.2
Linear-by-Linear Assoc 0.033 1 0.856 Linear-by-Linear Assoc 1.3 1 0.254
N of Valid Cases 104   N of Valid Cases 104   
Pearson Chi-Square 2.4 2 0.301 Pearson Chi-Square 0.755 2 0.685
Likelihood Ratio 3.198 2 0.202 Likelihood Ratio 1.165 2 0.559
Linear-by-Linear Assoc 0.144 1 0.704 Linear-by-Linear Assoc 0.742 1 0.389
N of Valid Cases 104   N of Valid Cases 104   
 Test Value df Asymp. Sig. (2-sided)
Exact Sig. 
(2-sided)
Exact Sig. 
(1-sided)
Pearson Chi-Square 0.39 1 0.532   
Continuity Correction 0 1 1   
Likelihood Ratio 0.735 1 0.391   
Fisher's Exact Test    1 0.694
Linear-by-Linear Assoc 0.386 1 0.534   
N of Valid Cases 104     
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Figure 48: Cross tabulation: Support for ED Vacc v. Barriers to ED Vacc 
 
 
 
 
 
Disagree Neutral Agree Disagree Neutral Agree Disagree Neutral Agree Disagree Neutral Agree Disagree Neutral Agree
Count 5 15 47 67 6 7 54 67 0 2 65 67 5 6 56 67 6 8 53 67
% within 
Support 7.5% 22.4% 70.1% 100.0% 9.0% 10.4% 80.6% 100.0% 0.0% 3.0% 97.0% 100.0% 7.5% 9.0% 83.6% 100.0% 9.0% 11.9% 79.1% 100.0%
% within 
Barrier 21.7% 75.0% 77.0% 64.4% 40.0% 46.7% 73.0% 64.4% 0.0% 28.6% 71.4% 64.4% 45.5% 42.9% 70.9% 64.4% 42.9% 66.7% 67.9% 64.4%
% of Total 4.8% 14.4% 45.2% 64.4% 5.8% 6.7% 51.9% 64.4% 0.0% 1.9% 62.5% 64.4% 4.8% 5.8% 53.8% 64.4% 5.8% 7.7% 51.0% 64.4%
Count 18 5 14 37 9 8 20 37 6 5 26 37 6 8 23 37 8 4 25 37
% within 
Support 48.6% 13.5% 37.8% 100.0% 24.3% 21.6% 54.1% 100.0% 16.2% 13.5% 70.3% 100.0% 16.2% 21.6% 62.2% 100.0% 21.6% 10.8% 67.6% 100.0%
% within 
Barrier 78.3% 25.0% 23.0% 35.6% 60.0% 53.3% 27.0% 35.6% 100.0% 71.4% 28.6% 35.6% 54.5% 57.1% 29.1% 35.6% 57.1% 33.3% 32.1% 35.6%
% of Total 17.3% 4.8% 13.5% 35.6% 8.7% 7.7% 19.2% 35.6% 5.8% 4.8% 25.0% 35.6% 5.8% 7.7% 22.1% 35.6% 7.7% 3.8% 24.0% 35.6%
Count 23 20 61 104 15 15 74 104 6 7 91 104 11 14 79 104 14 12 78 104
% within 
Support 22.1% 19.2% 58.7% 100.0% 14.4% 14.4% 71.2% 100.0% 5.8% 6.7% 87.5% 100.0% 10.6% 13.5% 76.0% 100.0% 13.5% 11.5% 75.0% 100.0%
% within 
Barrier 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
% of Total 22.1% 19.2% 58.7% 100.0% 14.4% 14.4% 71.2% 100.0% 5.8% 6.7% 87.5% 100.0% 10.6% 13.5% 76.0% 100.0% 13.5% 11.5% 75.0% 100.0%
Disagree Neutral Agree Disagree Neutral Agree Disagree Neutral Agree Disagree Neutral Agree Disagree Neutral Agree
Count 32 20 15 67 32 22 13 67 18 15 34 67 26 33 8 67 15 32 20 67
% within 
Support 47.8% 29.9% 22.4% 100.0% 47.8% 32.8% 19.4% 100.0% 26.9% 22.4% 50.7% 100.0% 38.8% 49.3% 11.9% 100.0% 22.4% 47.8% 29.9% 100.0%
% within 
Barrier 55.2% 71.4% 83.3% 64.4% 57.1% 62.9% 100.0% 64.4% 56.3% 65.2% 69.4% 64.4% 54.2% 73.3% 72.7% 64.4% 46.9% 78.0% 64.5% 64.4%
% of Total 30.8% 19.2% 14.4% 64.4% 30.8% 21.2% 12.5% 64.4% 17.3% 14.4% 32.7% 64.4% 25.0% 31.7% 7.7% 64.4% 14.4% 30.8% 19.2% 64.4%
Count 26 8 3 37 24 13 0 37 14 8 15 37 22 12 3 37 17 9 11 37
% within 
Support 70.3% 21.6% 8.1% 100.0% 64.9% 35.1% 0.0% 100.0% 37.8% 21.6% 40.5% 100.0% 59.5% 32.4% 8.1% 100.0% 45.9% 24.3% 29.7% 100.0%
% within 
Barrier 44.8% 28.6% 16.7% 35.6% 42.9% 37.1% 0.0% 35.6% 43.8% 34.8% 30.6% 35.6% 45.8% 26.7% 27.3% 35.6% 53.1% 22.0% 35.5% 35.6%
% of Total 25.0% 7.7% 2.9% 35.6% 23.1% 12.5% 0.0% 35.6% 13.5% 7.7% 14.4% 35.6% 21.2% 11.5% 2.9% 35.6% 16.3% 8.7% 10.6% 35.6%
Count 58 28 18 104 56 35 13 104 32 23 49 104 48 45 11 104 32 41 31 104
% within 
Support 55.8% 26.9% 17.3% 100.0% 53.8% 33.7% 12.5% 100.0% 30.8% 22.1% 47.1% 100.0% 46.2% 43.3% 10.6% 100.0% 30.8% 39.4% 29.8% 100.0%
% within 
Barrier 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
% of Total 55.8% 26.9% 17.3% 100.0% 53.8% 33.7% 12.5% 100.0% 30.8% 22.1% 47.1% 100.0% 46.2% 43.3% 10.6% 100.0% 30.8% 39.4% 29.8% 100.0%
Disagree Neutral Agree Disagree Neutral Agree Disagree Neutral Agree
Count 62 5 0 67 15 11 41 67 45 16 6 67
% within 
Support 92.5% 7.5% 0.0% 100.0% 22.4% 16.4% 61.2% 100.0% 67.2% 23.9% 9.0% 100.0%
% within 
Barrier 63.3% 83.3% 0.0% 64.4% 60.0% 78.6% 63.1% 64.4% 62.5% 64.0% 85.7% 64.4%
% of Total 59.6% 4.8% 0.0% 64.4% 14.4% 10.6% 39.4% 64.4% 43.3% 15.4% 5.8% 64.4%
Count 36 1 0 37 10 3 24 37 27 9 1 37
% within 
Support 97.3% 2.7% 0.0% 100.0% 27.0% 8.1% 64.9% 100.0% 73.0% 24.3% 2.7% 100.0%
% within 
Barrier 36.7% 16.7% 0.0% 35.6% 40.0% 21.4% 36.9% 35.6% 37.5% 36.0% 14.3% 35.6%
% of Total 34.6% 1.0% 0.0% 35.6% 9.6% 2.9% 23.1% 35.6% 26.0% 8.7% 1.0% 35.6%
Count 98 6 0 104 25 14 65 104 72 25 7 104
% within 
Support 94.2% 5.8% 0.0% 100.0% 24.0% 13.5% 62.5% 100.0% 69.2% 24.0% 6.7% 100.0%
% within 
Barrier 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
% of Total 94.2% 5.8% 0.0% 100.0% 24.0% 13.5% 62.5% 100.0% 69.2% 24.0% 6.7% 100.0%
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Figure 49: Chi-Square analysis: Support for ED Vacc v. Barriers to ED Vacc 
 
 
Figure 50: Comments provided by ED directors. 
Comments 
"We have discussed in past and had resistance from community physicians that we would be 
interfering in their provision of care - probably some concern about continuity and smooth 
transmission of record of vaccination, but clearly also a business concern about lost patient 
visits in office." 
"Just don't have the resources for immunization, DV, falls, diabetes, COPD, etc. screening." 
 Test Value df Asymp. Sig. (2-sided)  Test Value df
Asymp. Sig. 
(2-sided)
Pearson Chi-Square 23.5 2 0 Pearson Chi-Square 8.512 2 0.014
Likelihood Ratio 23.1 2 0 Likelihood Ratio 12.73 2 0.002
Linear-by-Linear Assoc 18.92 1 0 Linear-by-Linear Assoc 6.388 1 0.011
N of Valid Cases 104   N of Valid Cases 104   
Pearson Chi-Square 8.327 2 0.016 Pearson Chi-Square 1.466 2 0.48
Likelihood Ratio 8.116 2 0.017 Likelihood Ratio 1.452 2 0.484
Linear-by-Linear Assoc 7.767 1 0.005 Linear-by-Linear Assoc 1.408 1 0.235
N of Valid Cases 104   N of Valid Cases 104   
Pearson Chi-Square 16.74 2 0 Pearson Chi-Square 4.093 2 0.129
Likelihood Ratio 18.14 2 0 Likelihood Ratio 4.105 2 0.128
Linear-by-Linear Assoc 16.46 1 0 Linear-by-Linear Assoc 3.211 1 0.073
N of Valid Cases 104   N of Valid Cases 104   
Pearson Chi-Square 6.007 2 0.05 Pearson Chi-Square 7.621 2 0.022
Likelihood Ratio 5.816 2 0.055 Likelihood Ratio 7.68 2 0.021
Linear-by-Linear Assoc 4.909 1 0.027 Linear-by-Linear Assoc 2.185 1 0.139
N of Valid Cases 104   N of Valid Cases 104   
Pearson Chi-Square 3.29 2 0.193 Pearson Chi-Square 1.488 2 0.475
Likelihood Ratio 3.147 2 0.207 Likelihood Ratio 1.587 2 0.452
Linear-by-Linear Assoc 2.733 1 0.098 Linear-by-Linear Assoc 0.003 1 0.956
N of Valid Cases 104   N of Valid Cases 104   
Pearson Chi-Square 5.573 2 0.062 Pearson Chi-Square 1.503 2 0.472
Likelihood Ratio 5.89 2 0.053 Likelihood Ratio 1.719 2 0.423
Linear-by-Linear Assoc 5.482 1 0.019 Linear-by-Linear Assoc 0.931 1 0.335
N of Valid Cases 104   N of Valid Cases 104   
 Test Value df Asymp. Sig. (2-sided)
Exact Sig. 
(2-sided)
Exact Sig. 
(1-sided)
Pearson Chi-Square 0.993 1 0.319   
Continuity Correction 0.311 1 0.577   
Likelihood Ratio 1.114 1 0.291   
Fisher's Exact Test    0.418 0.301
Linear-by-Linear Assoc 0.984 1 0.321   
N of Valid Cases 104     
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"We can do all the things society wants like immunizations, HIV screening, asthma 
education, smoking cessation, domestic violence screening:  Where does it end, we need 
appropriate resources and staff and space and we can take on more but when every day is a 
crisis, routine, non-emergent things will have to wait." 
"ED immunizations would lead to over-immunization of the public because most patients 
honestly do not know what their immunization status is." 
"I am very hesitant about adding ANYTHING to ED Physicians who are already 
overburdened." 
"Number one reason. It will increase total volume significantly, during immunization season. 
No mechanism in the ED just to give immunizations in triage. Not enough triage staff to do 
their job at present let alone the additional responsibility of immunizing our community." 
"Just like many other functions that the state has dumped on the ED, this is not one that 
should be assumed." 
"My concern is the  time it would take away from true emergency patients. It's not just 
giving the vaccine but also the teaching and Q&A that would cause increase LOS." 
"Cost effectiveness of using EDs as a vaccination center from a societal standpoint not yet 
done  Unclear whether this activity would be reimbursed as emergency care and thus provide 
the funding to ensure that this would remain a budget neutral item for the hospital  Mistake 
to focus on the EDs to try and solve primary care shortages (the real cause of the problem) 
rather than improve access to primary care as it increases the cost of health care  Shortage 
of ED space as, in time of fear of epidemics, many patients may decide to use the ED for 
vaccinations exacerbating crowding." 
"Patients and providers do not expect vaccination screening in the ED any more than they 
would expect cholesterol checks or PSA screening." 
"The ED does not need to replace the PCP." 
"Would not support routine vaccine administration in ED except in serious public health 
emergency. This is a function best left to public health departments and PCP's. ED lack the 
capacity to care for current levels of emergency patients without adding routine preventive 
care." 
"If we can give Tdap--we should all be able to provide flu & pneu vaxs." 
"Improper use of scarce/busy ED resources - do not want to train the population to use ED 
for non-emergent care. Patient co-pays." 
"EDs cannot be all things to all people, and are increasingly dumping grounds for everything 
everyone else does not want to or cannot do.  Although I strongly agree with immunization, 
burdening the ER with this primarily "primary care" activity is simply not a good idea, we 
simply to not have the time or the resources." 
"An idea that has been proposed in the past.  However, not an effective use of resources for 
EDs built for high acuity.  Would be best served in urgi care centers." 
"There exist only certain type of patients that would benefit from ED immunization, mainly 
those without PCP's or good access.  The PCP's do not want us immunizing their patients." 
"It is not always so easy to obtain the vaccinations in the ED." 
"Converting ED's into office practice structures will only confound are already overcrowded, 
over-utilized, underfunded operations.  Let us do emergency care and don't make us into a 
newer model of primary care access!" 
"Important question with interesting implications." 
"The ED should not be the location for performance of primary care functions." 
"My opposition is strictly based on lack of available resources to add this to the existing 
work." 
"We are screening for everything from domestic violence to street drug abuse.  Our 
resources are limited and additional immunizations are likely to push us toward longer 
lengths of stays in the ED and more patients leaving without being seen." 
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"ED care is the most expensive way of delivering care.  This is a public health measure." 
"I have supported this concept for more than 25 years." 
"Don't feel we need to do in our small community with a medical home/EMR connection 
coming shortly." 
"ED's are overcrowded already. We have enough trouble ensuring tetanus status is UTD." 
"Many patients do not know whether they have been immunized against pneumococcus, and 
yet they have a relationship with a PCP.  It is not clear that providing immunizations to these 
folks would make sense in the ED." 
"It should not fall on already overstressed Emergency Departments to make up the many 
failures of other components of the healthcare system.  I can take out an appendix too; it 
just isn't effective/efficient practice." 
"We would have to add nursing FTE's which we can't do and it would slow our flow which 
would adversely affect care." 
"We are piloting a program with our clinical pharmacist this spring." 
"Overburdened, overcrowded EDs should not bear the brunt of this public health challenge.  
We are losing the meaning of the word emergency in emergency dept." 
"I am just concerned that the safety net of the ED is constantly expanding." 
"Not the role of the ED." 
"The largest barrier are that our patients are resistant to routine immunizations." 
 
 
 
